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Exercise induced bronchoconstriction (EIBC) occurs in response to high ventilations 
during exercise, which cools and dries the airways, triggering an inflammatory cascade. 
High intensity interval training (HIIT) is associated with reductions in inflammation, 
improvements in cardiorespiratory outcomes, and mental health in healthy adults; 
however, the impact of HIIT in adults with EIBC is unclear. The purpose of this 
dissertation was to determine the impact of a 6-week HIIT intervention on physiological 
(e.g. inflammation, ventilation, and cardiorespiratory fitness) and psychological (i.e. 
anxiety) domains of health among adults with EIBC and healthy adults, and the impact of 
HIIT on clinical outcomes (i.e. asthma control) among adults with EIBC. METHODS: A 
quasi-experimental study design was used. A 6-week HIIT intervention was implemented 
in adults (18-44 years) with EIBC and healthy controls. Sessions were conducted three 
times per week and consisted of cycling at 10% PPO for 1 minute followed by 90% PPO 
for 1 minute, repeated 10 times. Primary measures at pre (T1) and post-intervention (T2) 
included: 1) maximal exercise test 2) passive drool saliva samples 3) anxiety sensitivity 
index-3 4) asthma control questionnaire-7 (EIBC group only). RESULTS: Participants in 
the EIBC group (n=20; T1: 32.9 ± 8.0; T2: 38.6 ± 8.2 ml/kg/min, p<0.01) and control 
group (n=12; T1: 38.6 ± 8.2; T2: 38.9 ± 12.3 ml/kg/min, p<0.01) improved VO2max. 
Adults with EIBC had lower levels of IL-1Ra at T2 when compared to healthy controls 
(EIBC T2: 0.2 ± 0.16pg/ug protein; Control T2: 0.8 ± 0.21pg/ug protein; p<0.01, hp
2 = 
0.3). Maximal ventilation in the EIBC group did not improve (EIBC T1: 97.8 ± 22.2; 
EIBC T2: 108.7 ± 29.5, p=0.7, Cohens d=0.4); however, the control group improved 
ventilation at the same absolute exercise workload (Control T1: 82.8 ± 20.1; Control T2: 
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101.8 ± 18.1, p=0.02). Reductions in anxiety sensitivity (EIBC T1: 17.9 ± 11.8; EIBC 
T2: 12.4 ± 13, p=0.002, Cohens d=0.4) and asthma control (EIBC T1: 0.8 ± 0.6; EIBC 
T2: 0.5 ± 0.4, p=0.02, Cohens d=0.5) from T1 to T2 occurred. CONCLUSION: A 6-
week HIIT intervention leads to improvements in physiological, psychological, and 
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Chapter 1 - General Overview 
Asthma is defined as a respiratory condition characterized by chronic inflammation 
and acute bronchoconstriction [1]. Currently, the prevalence of asthma among Canadians 
is approximately 8% [2]. Of the almost three million Canadians with a diagnosis of asthma, 
approximately 90% experience exercise induced bronchoconstriction (EIBC) [3]. EIBC 
is triggered by the increase in ventilation that occurs during exercise, which increases the 
evaporative water and heat loss from the lungs and triggers an inflammatory response 
causing bronchoconstriction [4]. For the purpose of this dissertation the term asthma will 
be used when referring to the overall chronic condition, and EIBC will be used when 
specifically referring to the physiological response to exercise. 
Asthma cannot be cured, therefore, the clinical goal is management of asthma 
symptoms. Asthma control is determined by assessing the frequency of asthma 
symptoms such as dyspnea, coughing, wheezing, chest tightness, and limitations of daily 
activities (e.g. exercise participation) [5].  It can range from complete (experiencing no 
symptoms during any activity) to not at all (experiencing symptoms all the time). Poor 
asthma control is associated with lower quality of life and an increased risk of developing 
anxiety, depression [6], and higher levels of systemic inflammation (assessed via serum) 
[7].  
The aforementioned associations among asthma control, anxiety, depression, and 
inflammation point to the interconnectedness of these domains of health. Figure 1 
illustrates this interconnectedness, beginning with  higher levels of systemic and local 
(airway) inflammation among adults with asthma (Step 1). Regular exercise has been 
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shown to elicit a plethora of health benefits among adults with asthma and as such, is 
often recommended to patients (Step 2) When adults with asthma participate in an acute 
bout of exercise, ventilation increases  to meet the increased oxygen demand of the 
working muscles (Step 3). This increase in ventilation could be misinterpreted as a 
precursor to an asthma attack, trigger a further anxiety related increase in ventilation 
adding to the cooling and drying of the airways and thus, exacerbate the 
bronchoconstriction [4]. The cooling and drying of the airways elicits an influx of 
inflammatory mediators to the airways (Step 4) and lead to a reduction in forced 
expiratory volume in 1 second (FEV1), and trigger EIBC symptoms (Step 5). 
Bronchoconstriction and EIBC symptoms following acute exercise may lead to higher 
anxiety surrounding exercise participation in fear of experiencing an asthma attack and 
may lead to exercise avoidance (Step 6) [8]. Exercise avoidance leads to worse asthma 
control (e.g. increase in asthma symptoms) (Step 7).   
Regular exercise training has been shown to reduce inflammation [9] and improve asthma 
management (i.e. reduce symptoms, improve asthma control) [10]. Therefore, it is 
pertinent that adults with asthma participate in exercise that allows them to do so without 
experiencing the negative symptoms described above and in Figure 1. Asthma control has 
been associated with various physiological outcomes in that, higher levels of 
inflammation and higher levels of anxiety have been associated with worse asthma 
control [11, 12]. It is clear that each domain of health contributes to the overall 
management of asthma therefore, the impact of HIIT within each domain of health will 
allow for a better understanding of the benefits of HIIT among this population. 
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Figure 1. The multi-faceted responses to exercise and how these response can contribute to exercise avoidance 
and thus, poor clinical outcomes among adults with asthma. In response to an asthma diagnosis, exercise should 
be prescribed; however, the acute responses (ventilation increases, inflammation increases, reductions in FEV1 












Exercise training leads to improved maximal oxygen uptake (VO2max) [13], 
reduced risk of developing chronic disease [14], reduced systemic inflammation [15], and 
improved mental health [16]. Among adults with a chronic condition such as asthma, 
regular exercise has been shown to have clinical benefits such as improvements in asthma 
control [10]. Despite these benefits, many Canadians are not sufficiently active [17]. 
There are many possible reasons as to why Canadians are not meeting the minimum 
guidelines. In particular, perceived barriers such as lack of time, lack of motivation, lack 
of enjoyment, and poor health have been cited [18].  Due to the high prevalence of EIBC 
among adults with asthma, EIBC symptoms, and anxiety surrounding EIBC symptoms 
may serve as additional barriers.  
My masters work showed that among adults with EIBC, an acute bout of HIIT led 
to a smaller reduction in lung function (i.e. smaller reductions in FEV1 post-exercise) when 
compared to continuous exercise [19]. This smaller reduction in FEV1 following HIIT was 
hypothesized to be due to the intermittent recovery intervals associated with HIIT which 
would allow for ventilation to recover intermittently and thus, reduce the amount of 
evaporative water and heat loss from the airways. This is of particular importance because 
a reduction in the amount of water and heat loss from the airways may contribute to a 
reduction in EIBC symptoms as a result of exercise participation [4]. One of the limitations 
of this work was that we did not monitor ventilation during the exercise sessions, thus, the 
role of ventilation remained unclear. Another limitation was that there was no control group 
so it remained unclear as to whether differences in ventilation responses occurs during 
HIIT between adults with and without EIBC [19]. Finally, this work also indicated that 
adults with EIBC experienced greater exercise enjoyment during HIIT when compared to 




other exercise protocols. With these limitations in mind, questions surrounding the 
physiological adaptations (e.g. inflammation, lung function) and psychological changes 
(e.g. anxiety, enjoyment) to HIIT and the differences in these responses between adults 
with EIBC and healthy adults arose and as such, formed the basis for this dissertation.  
The overarching goal of this body of work was twofold. First, this work sought to 
better understanding the impact of HIIT on physiological, psychological, and clinical 
outcomes in response to a low-volume 6-week HIIT among adults with EIBC and healthy 
adults. Second, this work sought to elucidate the interconnectedness between the 
physiological, psychological and clinical outcomes associated with asthma in response to 









2.0 REVIEW OF THE SCIENTIFIC LITERATURE 
2.1 Introduction  
The following literature review details the physiological variables (i.e. inflammation, 
lung function, ventilation, and cardiovascular), psychological variables (i.e. anxiety and 
enjoyment), and clinically relevant variables (i.e. asthma control) that were assessed 
during the 6-week HIIT intervention implemented among adults with and without EIBC.  
For the purpose of this review, acute exercise is defined as a single bout of exercise; 
whereas, exercise training is defined as repeated bouts of exercise. 
2.2 High Intensity Interval Training 
HIIT is composed of brief bouts of high intensity activity followed by intermittent 
recovery periods. It is a time-efficient form of exercise and has been shown to be safe and 
effective among healthy populations as well as among those with chronic condition such 
as diabetes [20], cardiovascular disease [21], and chronic obstructive pulmonary disease 
(COPD) [22].  
Among healthy adults, HIIT has been shown to improve physical fitness (i.e. maximal 
oxygen consumption (VO2max)), physiological functions (i.e. reductions in 
inflammation), and cardiovascular disease factors [23, 24]. In addition to these 
improvements, HIIT is perceived as a more enjoyable form of exercise training when 
compared to moderate intensity and vigorous intensity continuous exercise training 
among adults with EIBC [25]. There are many possible reasons as to why HIIT is 
perceived as the more enjoyable choice of exercise training among healthy adults. One 
possible reason may be related to its’ time-efficient nature paired with its success in 




physiological changes (i.e. body weight reduction, improvements in physical fitness) 
when compared to traditional continuous exercise training [26]. Secondly, it is possible 
that HIIT offers an added mental stimuli (i.e. changes in intensity during exercise) that 
continuous exercise lacks, thus minimizing boredom during exercise [27].  
Among adults with asthma, we have observed additional benefits of HIIT among adults 
with EIBC [19]. We have previously observed a reduction in FEV1 following an acute 
bout of HIIT (FEV1 reduction = -7.1% ± 8.3) compared to an acute bout of moderate 
intensity continuous exercise (FEV1 reduction = -14.8% ± 12.2) was significantly less 
(p= <0.001) [19] among adults with EIBC [19]. The less severe reduction in FEV1 may 
also lead to a reduction in EIBC related symptoms (i.e. perceived dyspnea) during and 
after exercise. A reduction in EIBC related symptoms during and following exercise 
offers another possible explanation for the preference for HIIT exercise among adults 
with EIBC. 
2.3 Pathophysiology of Asthma and EIBC 
 
The Immune Systems 
The immune system can be categorized into two major units, the innate and the adaptive 
immune systems. The innate immune system is employed to offer fast general protection 
against pathogens [28]. The adaptive immune system is not as fast acting upon first 
exposure to an antigen but offers more precise protection against pathogens and is able to 
remember an antigen using memory cells, which allow for a more efficient and faster 
response against a known antigen than the innate immune system [29].  




Asthma is a heterogeneous condition that occurs as a result of the interaction between 
genetic susceptibility and environmental influences. [30]  Asthma is often considered a 
disease of the adaptive immune system, exemplified by the fast acting inflammatory 
response that occurs upon exposure to a trigger (e.g. exercise) [31]. Although primarily a 
condition of the adaptive immune system, research has shown a network of innate 
immune cells (e.g. mast cells, epithelial cells, and dendritic cells) that become activated 
in response to a trigger. [32] Taken together, it is clear that asthma can no longer be 
considered only a condition of the adaptive immune system, and the interaction between 
the innate and adaptive immune systems must be considered in order to fully comprehend 
the asthma immune response. 
Asthma is one of the most prevalent conditions in Canada and continues to rapidly 
increase. One hypothesis that has been put forth to explain the increase in asthma 
prevalence that has gained considerable attention in the scientific literature, is the hygiene 
hypothesis. It is hypothesized that among those in industrialized nations (e.g. Canada) 
there is less exposure to microbes due to a variety of factors including better infection 
control, more immunizations, and better sanitation. [33] CD4+ helper T-lymphocytes 
have been divided into two sub-classes, Th1 and Th2, depending on the cytokines they 
secrete. The hygiene hypothesis suggests that exposure to microbes at a young age allows 
the immune response and immunological phenotype shift from a predominate Th2 to a 
Th1 phenotype as we age[34]; however, this exposure to microbes is reduced in more 
Westernized areas.  
 
 




Inflammation is the immune system’s response to harmful stimuli (i.e. damaged cells, 
pathogens) and serves to remove harmful stimuli and begin the healing process [35, 36].  
The inflammatory immune response is therefore a vital defense mechanism for health and 
allows tissues to restore to homeostasis [37]. The inflammatory response occurs due to 
numerous inflammatory mediators that participate in intracellular signaling pathways to 
induce a target response (i.e. bronchoconstriction). Pro-inflammatory cytokines such as 
interelukin-1Beta (IL-1 β), interleukin-6 (IL-6), and tumor necrosis factor-a (TNF-a) 
mediate the inflammatory response by interacting with receptors such as, IL-1 receptor 
(IL-1R), and the TNF receptor [37]. The activation of these receptors furthers the 
inflammatory response via intracellular signaling. The innate immune response is 
designed to protect us from potentially dangerous invaders; however, when the 
inflammatory process is unnecessarily triggered, health issues arise. 
Cytokines that are either pro or anti-inflammatory are responsible for facilitating or 
inhibiting the inflammatory response, respectively [38]. Cytokines are produced by cells 
to primarily recruit leukocytes to the site of injury (i.e. recruitment of leukocytes to the 
airways during an acute asthma exacerbation). IL-1 and TNF-a induce the release of 
various chemokines, which recruit different cell types (depending on the chemokine) to 
the site of injury., w[39]. Among adults without asthma or any respiratory condition, 
epithelial cells in the airways are the primary source of chemokines; however, among 
adults with asthma experiencing bronchoconstriction, infiltrated cells (e.g. mast cells, 
basophils, and macrophages) [40] within the submucosa become a major source of 
chemokines [41].  When there is excessive cytokine release, tissue damage, 
hemodynamic changes, organ failure, and death can occur [42].  When the acute 




inflammatory response becomes uncontrolled, the inflammatory response becomes 
chronic and thus, contributes to the development of various chronic conditions, such as 
asthma.  
The chronic inflammation associated with asthma results from various inflammatory 
cells, such as eosinophils, lymphocytes, and mast cells [43, 44]. These cells release 
various mediators of inflammation including cytokines, and additional mediators that can 
be classified into the following groups: pro-inflammatory cytokines, chemokines, growth 
factors, and eicosanoids [45]. The release of these inflammatory mediators contribute to 
bronchoconstriction, damage of the epithelium, and to the recruitment of additional 
leukocytes creating chronic inflammation, one of the key characteristics of asthma [45].   
Eosinophils are white blood cells that are a key feature in asthma and found in increased 
levels in the sputum of patients with asthma [46]. These higher levels of eosinophils in 
the airways of patients with asthma have been associated with more severe disease and 
contributed to the inflammation in the airways [46]. It has been suggested that 
eosinophils may play more of a role in the late asthmatic response [46, 47]. Specifically, 
within the airways of patients with asthma following exposure to a trigger, eosinophilic 
chemotactic factors are released. In response to their release, eosinophils arrive to the 
airways by means of migration through the vascular endothelium, upregulation of 
eosinophils, and adhesion of eosinophils to airway epithelium. Once in the airways, 
eosinophils promote obstruction, injury, and bronchial hyper-responsiveness [46]. 
Lymphocytes are a type of white blood cell categorized as either B-cells or T-cells. T-cell 
are developed in the thymus gland and play an important role in asthma [48]. T-
lymphocytes have been shown to be increased in the lungs of adults with asthma and 




more so during an acute exacerbation [49, 50]. Lymphocytes activate the release of 
various cytokines from other inflammatory cells, which in turn stimulates eosinophils and 
mast cells, contributing to further bronchoconstriction [49, 51].  
Mast cells mediate airway hypersensitivity, and were among the first cells to be 
associated with the pathogenesis of asthma [52]. Mast cells can be activated to release 
various mediators by multiple triggers (i.e. exercise as a trigger in EIBC). Mast cell 
activation occurs through the interaction between an antigen/allergen with its specific IgE 
antibody bound to its high affinity receptor on the membrane of a mast cell [53]. Once 
activated, the degranulation of mast cells release a variety of inflammatory mediators 
such as histamine and thus, in the context of asthma, contributes to furthering the 
bronchoconstriction of the airways. Histamine is well-known as an important chemical 
mediator for the immediate allergic reaction and is suggested to play a critical role in the 
pathophysiology of asthma [54]. There are four types of histamine receptors (H1, H2, H3, 
H4) in the airways and in the pulmonary tissue [55-57]. In a study of 18 adults with 
asthma and 18 controls, bronchial responsiveness was monitored during an increasing 
dosage of histamine challenge. Results showed that histamine induced 
bronchoconstriction is predominately meditated by the H1 receptors [58]. Histamine 
causes bronchoconstriction in response to exposure to a trigger by initiating contraction 
of the bronchial smooth muscle and the pulmonary peripheral tissue [59]. Anti-histamine 
medications are effective in reducing the decline in FEV1 [60] and have also been shown 
to be effective in EIBC [61]. In a study of 10 adults with EIBC, participants inhaled an 
anti-histamine and placebo on separate days, followed by an 8-minute exercise bout on a 
cycle-ergometer and FEV1 was assessed pre and post-exercise. Inhalation of the anti-




histamine resulted in a smaller reduction in FEV1 suggesting that histamine plays an 
important role in EIBC as well as allergic asthma [61]. 
As described, the inflammatory cascade associated with asthma is complex and occurs in 
response to a trigger. Importantly, these triggers vary between individuals with asthma. 
For the purpose of this review and PhD work, the focus will be on the trigger of exercise.  
Pathophysiology of EIBC 
Approximately 90% of adults with asthma experience EIBC [3]. The exact mechanisms 
responsible for EIBC remain unclear; however two hypotheses known as the osmotic and 
thermal hypotheses, have been suggest to explain the EIBC response [4].  
The osmotic hypothesis suggests that the increase in ventilation during exercise leads to 
an increase in evaporative water loss from the airways and thus, triggers an inflammatory 
response (described above). The thermal hypothesis suggests that it is the cooling of the 
airways as ventilation increases during exercise, and the subsequent rewarming of the 
airways when ventilation returns to normal post-exercise, that is responsible for 
triggering the inflammatory response associated with EIBC [4]. Table 1 contains a list of 
cytokines that have been shown to respond to acute bouts [62] and to regular exercise 
training [63, 64] among adults, and their respective functions. In a review of both of these 
hypotheses it has been suggested that the EIBC response likely occurs as a result of both 
evaporative water loss and airway cooling and rewarming, due to changes in ventilation 
during exercise [4]. 
Thus, it is clear that ventilation plays an integral role in triggering the inflammatory 
response associated with EIBC. 




Table 1.1 Cytokines and their Functions 
Cytokine Family Main sources Function 
IL-1β IL-1 Macrophages, monocytes Pro-inflammatory, proliferation, 
apoptosis, differentiation 
IL-4 IL-4 Th-cells, mast cells Anti-inflammatory, T-cell and B-
cell proliferation, B-cell 
differentiation 




IL-8 CXCL8 Macrophages, epithelial 
cells, endothelial cells 
Pro-inflammatory, chemoattractant 
for neutrophils, angiogenesis 
IL-10 IL-10 Monocytes, T-cells, B-
cells 
Anti-inflammatory, key regulatory 
cytokine, decreases production of 
cytokines involved in macrophage 
activation 
IL-12 IL-12 Dendritic cells, 
macrophages, neutrophils 
Pro-inflammatory, cell 
differentiation, activates NK cell 
IL-11 IL-6 Fibroblasts, neurons, 
epithelial cells 
Anti-inflammatory, differentiation, 
induces acute phase protein 
TNF-α TNF Macrophages, NK cells, 
CD4+lymphocytes, 
adipocyte 
Pro-inflammatory, , cell 
proliferation, apoptosis,  




TGF-β TGF Macrophages, T cells, 
Epithelial cells 
Anti-inflammatory, inhibition of 
pro-inflammatory cytokine 
production 
IP-10 CXCL Monocytes, neutrophils, 
endothelial cells 
Pro-inflammatory, chemoattractant 
for macrophages, T cells, natural 
killer cells 




Anti-inflammatory, blocks binding 
of IL-1β and IL-1a to the IL-1 
receptor 
 
In summary, asthma is defined as a chronic respiratory condition characterized by chronic 
inflammation and acute bronchoconstriction. The development of asthma results in an 
inappropriate inflammatory response, primarily led by T-helper type (TH)-2 lymphocytes 
in response to various triggers. EIBC occurs in response to evaporative water and heat loss 
from the airways that occur as a result of changes in ventilation during and post-exercise 
  
2.4 Diagnosis and Assessment of Asthma and EIBC 
A diagnosis of asthma is based on a history of variable respiratory symptoms (i.e. 
wheeze, shortness of breath, cough) and confirmed variable expiratory airflow limitation 
[1]. Expiratory airflow limitation can be determined via a pulmonary function test (PFT) 




using spirometry. A PFT is a non-invasive test to determine lung volume, lung capacity, 
and flow rates [65]. 
Variable expiratory airflow limitation can be confirmed using the following methods, 
positive bronchodilator reversibility test, excessive variability in twice-daily peak 
expiratory flow over 2 weeks, positive exercise challenge test, positive bronchial 
challenge test, or excessive variation in lung function [66]. Table 2.1 summarizes the 
criteria for each of the confirmatory expiratory airflow limitation assessments listed 
above.  
Table 2.1 Methods and Diagnostic Criteria for the Confirmation of Variable 
Expiratory Airflow Limitation [66] 
Method  Diagnostic Criteria 
Positive bronchodilator reversibility test Increase in FEV1 >12% and >200mL from 
pre-medication to 10-15 minutes post-
medication.  
Excessive variability in twice-daily peak 
expiratory flow over 2 weeks 
Increase in FEV1 >12% and >200mL from 
pre corticosteriod treatment to 4 weeks of 
anti-inflammatory treatment 
Positive exercise challenge test Decline in FEV1 of >10% and >200mL 
from pre to post-exercise  
Positive bronchial challenge test Decline in FEV1 from baseline of >20% 
with standard doses of methacholine or 
histamine OR >15% decline with 




standardized hyperventilation, hypertonic 
saline or mannitol 
Excessive variation in lung function 
between visits (less reliable) 
Variation in FEV1 of >12% and >200mL 
between visits, outside of respiratory 
infections  
 
Exercise Challenge Tests 
EIBC can be diagnosed in a laboratory setting by either an exercise challenge test or via 
bronchial provocation challenge. The laboratory based exercise challenge test can be 
completed on a treadmill or cycle ergometer; two standardized protocols exist for 
conducting an exercise challenge test on a cycle ergometer. The first protocol is a single 
load, at an exercise intensity of 45% to 60% of the predicted maximum voluntary 
ventilation (MVV) for 6 to 8 minutes [67]. The second protocol is an increasing protocol, 
which begins at an exercise intensity of 60% of the final load in the first minute, then 
75% in the second minute, 90% in the third minute and 100% in the fourth minute. Once 
the target level is reached, the workload is held for 4 minutes [68]. The standardized 
treadmill protocol recommends a speed and grade to produce 4 to 6 minutes at near 
maximum heart rate, with a total exercise duration of 6 to 8 minutes. During the first 2 to 
3 minutes, the treadmill speed and grade are rapidly increased until the participant 
achieves a heart rate of 80% to 90% of the maximum predicted. PFT is measured with 
regular intervals for up to 30 minutes following completion of either challenge [67]. As 
highlighted in Table 1, an exercise challenge test is deemed positive if there is a decline 
in FEV1  of 15% or greater from pre to post-exercise.  




Exercise challenge tests increase ventilation and thus, lead to evaporative water and heat 
loss from the airways triggering the inflammatory EIBC response. An exercise challenge 
assessment is time and cost-effective and has been shown to be specific for assessing 
EIBC. The disadvantage to this method however, is that it is not performed in the same 
environment that exercise is usually performed (i.e. no environmental stimuli) and can be 
improperly conducted if attention isn’t given to the proper protocols and timing of FEV1 
assessment post-exercise.  
 
Eucapnic voluntary Hyperpnea (EVH) challenge 
The EVH challenge is a sensitive and specific diagnostic method that triggers EIBC by 
hyperventilation of safe concentrations of dry gases (5% CO2, 21% O2, and balance N2 
that simulate ventilation for a period of 6 minutes [69]. The dry air is inhaled using a one-
way mouthpiece and exhaled breath is analyzed using a metabolic cart. Figure 2 
illustrates the EVH set-up.  




Figure 2. Eucapnic Voluntary Hyperpnea Challenge
Prior to an EVH challenge participants are asked to refrain from taking short acting 
bronchodilators for 8 hours and to refrain from taking long acting or sustained release 
bronchodilators for 48 hours in order to maximize the airway response. Prior to the EVH 
challenge, FEV1 is measured three times and the highest FEV1 value obtained at baseline 
is used to determine target ventilation during the EVH challenge. Previous literature has 
shown that a ventilation rate of 21x FEV1 at baseline is sufficient to elicit a positive 




response among adults with asthma and a target ventilation rate of 30x FEV1 at baseline 
is sufficient to elicit a positive response among those without a diagnosis of asthma[69]. 
Figure 3 provides a visual representation of a participant completing the EVH challenge.  
Following the 6-minute challenge, FEV1 is assessed again following the challenge at 
minutes 5, 10, 15 and 20-post challenge [70]. The percent decline between the FEV1 
obtained pre-challenge and the FEV1 obtained post-challenge is used to determine the 
airway response. Discrepancy exists 
regarding the FEV1 decline criteria post-
EVH to confirm EIBC. Previous studies 
have used a decline of 10%, 12%, 15%, 
and 20% as a diagnostic criteria. The 
EVH challenge has a very high 
sensitivity and is recommended by the 
International Olympic Committee- 
Medical Commission[67]. Thousands of 
EVH challenges have been performed 
without serious unwanted side effects, 
making it a safe and effective diagnostic 
tool[71]. 
Although many methods exist for the diagnosis of EIBC, many adults are diagnosed via a 
history of respiratory symptoms only. As such, many adults with a prescription for an 
inhaled bronchodilator may not have a positive response to the EIBC diagnostic tests. In 
order to ensure an EIBC diagnosis, efforts should be made to conduct one if not two of 
Figure 3. Participant Completing the 
EVH Challenge 




the confirmatory EIBC tests listed above. The EVH is considered the gold standard in a 
laboratory setting and as such, if equipment is available, this challenge should be 
conducted in order to confidently confirm EIBC. A second method of EIBC 
confirmation, such as the bronchodilator reversibility test, would add confidence to the 
EIBC diagnosis. The EVH challenge was conducted for the current PhD work in order to 
ensure that participants included in the EIBC group had a confirmed diagnosis of the 
condition. These confirmation assessments of EIBC added strength to the methodology 
and subsequent findings from this work.  
2.5 Asthma and EIBC Management  
Following an asthma or EIBC diagnosis, treatment and management options are 
discussed and implemented. The goal of asthma management as outlined by the Global 
Initiative for Asthma, is to achieve good symptom control, minimize risk of asthma 
related mortality, exacerbations, airflow limitation, and side-effects of treatment [72]. 
The pharmacological recommendations for the management of asthma among adults is 
inhaled corticosteroids (ICS) controller treatment either as-needed or daily, depending on 
the severity of the condition. The ICS controller treatment is used to reduce the risk of 
serious exacerbations and to control asthma related symptoms [73].  
 
Asthma medications can be divided into two main categories, controller medications and 
reliever (rescue) medications [1]. Controller medications are used to reduce the chronic 
airway inflammation associated with asthma. As well, controller medication is used to 
control asthma related symptoms, reduce future risks of an asthma exacerbation, and 
reduce the decline in lung function. Reliever, or rescue medication, are used to provide 
adults with asthma with relief from asthma related symptoms on an as-needed basis, 




either during worsening asthma or during an acute asthma exacerbation. During an acute 
exacerbation (i.e. following exercise participation), bronchoconstriction occurs due to the 
influx of various pro-inflammatory cytokines (described below). These cytokines trigger 
constriction of the bronchioles, which narrows the passageway for air to pass through 
thus, lowering FEV1. Furthermore, these cytokines increase mucous production in the 
airways, which creates further obstruction for air to pass through and causes an increase 
in asthma symptoms such as coughing. To prevent an acute EIBC exacerbation, rescue 
medication should be taken 15 minutes prior to exercise participation [72].  
Inflammatory Cytokines 
As highlighted above, EIBC occurs due to evaporative heat and water loss from the 
airways, which triggers an inflammatory cascade responsible for bronchoconstriction and 
asthma related symptoms (i.e. coughing, wheezing, chest tightness). Assessing 
inflammation via cytokines poses various difficulties. For example, circulating cytokines 
can be degraded by sample collection protocols (i.e. sample handling, processing and 
storage). Time of day in which the sample is collected has been shown to play an 
important role in obtaining accurate measures of inflammation, due to many immune 
systems experiencing oscillations within the 24-hour period [74, 75].  Cytokine samples 
are most commonly collected via serum or plasma samples. When assessing cytokines 
via serum samples, fibrinogen, platelets, and other circulating proteins must be removed. 
This removal and coagulation process can trigger the release of inflammatory mediators 
(e.g. histamine, eicosanoids) that may affect cytokine levels [76]. As such, plasma has 
been shown to produce the most consistent results for many cytokines [77, 78]. 
Furthermore, during acute exercise muscle cells release various cytokines that can be 




detected via plasma [79]. Serum and plasma samples should be collected in sterile tubes, 
chilled, and processed quickly in order to maintain cytokine stability [77]. The stability of 
cytokines are further impacted by the short-half life, the production of cytokines by cells 
in the peripheral blood preparations, and the potential degradation. Although there are 
many factors that may negatively impact the integrity of the cytokines within serum and 
plasma, these methods of cytokine assessment are commonly used. Of note, the 
feasibility of these methods may be considered a disadvantage. Serum and plasma sample 
collection requires the skills of trained professionals (i.e phlebotomist) and require 
participants to consent to venous blood or arterial blood sampling. Therefore, many 
participants may not be willing or comfortable with needles, which has been shown to 
lead to health care avoidance and thus, may limit the use of this form of measurement 
[80]. Thus, research examining a non-invasive method of measuring cytokines is 
warranted.  
Saliva is an exocrine secretion from the salivary glands and is composed of water (99%), 
electrolytes, proteins, and enzymes [81]. Whole saliva is composed of a mixture of fluids, 
secreted from the submandibular, sublingual, parotid, and the minor gland and mucous 
from the nasal cavity and pharynx (see Figure 1) [82]. Approximately 65% of 
unstimulated, or resting, saliva comes from the submandibular gland, 25% from the 
parotid gland, 4% from the sublingual gland, and 8% from other salivary glands [83]. The 
submandibular gland is considered to be a mucosal effector tissue and contains T cells, B 
cells, and dendritic cells [84]. These cells are all part of the oral immune system and are 
able to produce various cytokines, while the B cells produce antibodies [85]. Saliva 
secretion by the major and minor salivary glands is regulated through neurotransmitter 




stimulation and secretion is often referred to as a two-step process [86]. Step one involves 
the secretion of an isotonic primary fluid by the acinar cells (water-permeable) and step 
two occurs in the duct system and involves the re-absorption of most sodium and 
potassium [87].  The acinar glands are also the site of the majority of protein secreted into 
the saliva (approximately 80%), with the remaining 20% of protein being secreted from 
the duct cells [88].  
Figure 4. Salivary Glands 
Salivary collection and 
analysis is a non-invasive 
method of assessing 
inflammation and easily 
allows for repeated measures 
per day over time. There are 
two collection methods for 
saliva: passive drool or oral 
swab. Many researchers 
consider the passive drool 
method the gold standard for 
collecting saliva samples for 
biological testing because it allows for the purest sample possible [89]. Samples 
collected using this method ensures that the saliva collected is a mixture of saliva 
secreted from all glands. The swab method of obtaining saliva, on the other hand, 











Furthermore, the swab method is less representative of whole saliva given that it 
remains in the same area of the mouth and thus, the majority of the saliva 
collected results from secretion from the sublingual gland.  
Cytokines can be reliably assessed via saliva and are responsive to exercise. In a study of 
10 physically active males who completed a 60 minutes of cycling exercise stressor at 
75% VO2max and  a resting control condition (reading or writing silently) on different 
days at least seven days apart, saliva samples were taken immediately before, 
immediately after, one hour after, and two hours after task completion [91]. TNF-α levels 
significantly increased during the exercise stress session compared to the control resting 
session (p < .01), with levels highest immediately after the completion of the 60-minute 
stressor [91]. As well, levels of IL-6 significantly increased during the exercise stress 
session compared to the control resting session (p < .01), with levels highest immediately 
after the completion of the 60-minute stressor. Levels of IL-1β significantly increased 
during the exercise stress session compared to the control resting session (p < .01), with 
levels highest immediately after the completion of the 60-minute stressor [91]. Similar 
findings were reported with IL-1β in a study of 30 participants (male n=20, female n=10) 
who completed a one-hour competitive rafting competition [92]. Saliva samples were 
obtained before and immediately after the competition. There was a significant increase 
(p = .01) in IL-1β concentrations before and after the exercise [92].  These findings 








2.6 Inflammation, Exercise, and EIBC 
The cytokines  highlighted in the section below were chosen based on previous work 
highlighting their integral role in the acute and chronic inflammatory response to 
exercise, their role in exercise and acute bronchoconstriction (described above), and their 
successful assessment via saliva [93].  
In the section below, the following 4 pro-inflammatory markers TNF-a, IL-1β, IL-8, and 
Interferon (IFN)-gamma inducible protein, (CXCL10/IP-10) and the following 2 anti-
inflammatory markers, interleukin-1 Receptor antagonist (IL-1Ra) and TGF- β will be 
discussed as they relate to EIBC.  Following the description of these cytokines, this 
section will summarize previous literature examining the response of these cytokines to 
acute and chronic exercise. 
Pro-Inflammatory Markers 
TNF-a: TNF-a is primarily produced by macrophages and is an important cytokine in the 
innate immune response, providing immediate defense against invading organisms [94]. 
It has been shown to contribute to the dysregulation of the inflammatory response among 
individuals with asthma [95]. TNF-a further contributes to the inflammation observed in 
bronchoconstriction by regulating early neutrophil infiltration and eosinophil recruitment 
into the airways, which serves to amplify the inflammatory response [96]. It also 
increases epithelial expression of intercellular adhesion molecule-1 (I-CAM) and 
vascular cell adhesion molecule-1 (V-CAM1) [97]. The increased expression of these 
molecules play an important role in the migration of T cells to the airways and in the 
development of airway hyper-responsiveness [98].  




Among healthy adults, TNF-a has been shown to increase in response to acute exercise. 
Specifically, in a study of 10 adult males, salivary levels of TNF-a increased in response 
to a standardized treadmill test, using the standardized Bruce protocol. Levels of salivary 
TNF-a increased steadily at minutes 7 and 14 of exercise when compared to pre-exercise 
[99].  
The aforementioned studies clearly illustrate the important and complex role that TNF-a 
plays in the inflammatory response of asthma. However, the response of TNF-a 
following a HIIT intervention among adults with EIBC has not been studied. 
IL-1β: IL-1β is an innate immune cytokine that plays an important role in the initiation 
and persistence of inflammation [100]. IL-1β has been shown to play a role in the early 
phase of asthma as well as the altered airway response [101]. IL-1β is elevated in 
individuals with stable and exacerbating asthma [100]. As well, airway IL-1β is 
associated with systemic inflammation among individuals with asthma [100, 102]. In a 
prospective cohort study assessing airway IL-1β among individuals with asthma (n=63), 
it was reported that an increase in airway IL-1β and systemic inflammation was 
associated with an increased risk for an asthma exacerbation. There was increased IL-1β 
gene and protein expression among individuals with asthma, although it failed to reach 
statistical significance [102]. These initial findings warrant further investigation to better 
determine the role of IL-1β in the systemic inflammatory pathway among individuals 
with asthma. Among adults without asthma, salivary levels of IL-1β  have been shown to 
increase following an acute bout of exercise (60 minutes at 75% VO2max) when 
compared to a resting condition [91]. To date, no study has compared the IL-1β response 
to exercise between adults with and without asthma. However, in a study examining 




levels of IL-1β in sputum among adults with and without asthma, no differences were 
observed [103]. Research to understand the impact of exercise on salivary levels of IL-1β 
among adults with and without EIBC is warranted. 
IL-8: IL-8 is produced by a variety of tissue and blood cells, and acts as a 
chemoattractant cytokine. IL-8 plays a key role in the attraction and activation of 
neutrophils to areas of inflammation [104]. Adults with asthma have greater levels of IL-
8 when compared to adults without, and that higher levels of IL-8 are associated with 
worse asthma control [105]. IL-8 has been shown to be responsive to acute exercise, in 
that high intensity or exhaustive exercise with an eccentric component (e.g. motion of an 
active muscle while lengthening under load) elicits increases in systemic levels of IL-8 
[106]. Among healthy adults, an acute bout of high intensity interval exercise decreases 
serum levels of IL-8 [107]. Interestingly, an acute bout of high intensity exercise among 
adults with asthma (n=39)  increases plasma IL-8 immediately post-exercise and a return 
to baseline values 1 hour post-exercise [108]. A study examining the impact of moderate 
intensity aerobic exercise twice per week for 12-weeks versus no exercise among adults 
with asthma (n=58), found no differences in sputum IL-8 from pre to post-intervention or 
between groups [109]. The response of IL-8 to acute and chronic exercise among adults 
with asthma is inconclusive. Higher intensity exercise may allow for a more potent 
inflammatory stimulus and thus, elicit greater reductions in pro-inflammatory markers 
among adults with asthma when compared to those without. In summary, it appears that 
an acute bout of high intensity exercise may elicit different responses among those with 
and without asthma; however, the impact of adherence to chronic HIIT on IL-8 among 
adults with and without asthma remains unknown and warrants further investigation.   




CXCL10/IP-10: CXCL10/IP-10 is a member of the CXC chemokine family with pro-
inflammatory properties. CXCL10/IP-10 is secreted from leukocytes, neutrophils, 
eosinophils, monocytes, epithelia, and endothelial cells [110, 111]. CXCL10/IP-10 
preferentially attracts activated Th1 lymphocytes and is up-regulated in the airways of 
adults with asthma [112]. Aerobic exercise training among healthy adults reduces plasma 
levels of CXCL10/IP-10. Specifically, in a study of healthy adults (n=413) participants 
were randomized into 8 weeks of aerobic exercise, mindfulness-based stress reduction, or 
a wait-list group. Those in the aerobic exercise group experienced the greatest reductions 
in CXCL10/IP-10, and those reductions remained after a 6-week follow-up [113]. To 
date, no study has examined the acute or chronic impact of HIIT among adults with 
asthma on salivary CXCL10/IP-10. It is possible that chronic HIIT would reduce 
CXCL10/IP-10 among adults with asthma; however, given that adults with asthma tend 
to have an up-regulation of CXCL10/IP-10 it is likely that they would experience 
reductions in this cytokine.  
Anti-Inflammatory Markers 
IL-1Ra –IL-1Ra is a specific inhibitor for the IL-1 family. Specifically, IL-1Ra acts by 
blocking the IL-1 receptor and therefore, stops the pro-inflammatory effects of cytokines 
in the IL-1 family [114]. T-helper cells 1 and 2 are responsible for regulating the ratio 
between IL-1β and IL-1Ra [115]. Among healthy adults, exercise has been shown to 
increase plasma levels of IL-1Ra. In a study of 19 well-trained athletes, plasma IL-1Ra 
was assessed pre and post a 6 hour endurance run. Plasma IL-1Ra increased from 188 
pg/ml to 886 pg/ml [116]. Unfortunately, less is known about the acute and chronic 
response of IL-1Ra to exercise training among adults. However, the dysregulation of the 




IL-1β /IL-Ra ratio is important for the inflammation observed among adults with asthma 
[117].  It is possible that during an asthma attack, such as following an acute bout of 
exercise, adults with EIBC would exhibit greater levels of IL-1Ra when compared to 
controls, in an attempt to reduce inflammation associated with bronchoconstriction. 
Furthermore, chronic HIIT may allow for an adaptation that may reduce acute 
inflammation following a single exercise bout and thus, adults with and without EIBC 
may exhibit similar IL-1Ra profiles. 
TGF-β: TGF-β is produced by various cell types (i.e. epithelial cells, eosinophils, 
macrophages, and fibroblasts and plays a central role in airway smooth muscle 
remodeling and mucous production [118]. Strenuous exercise elicits increases in the 
plasma concentration of TGF-β among healthy, physically active adults [119]. 
Furthermore, moderate intensity (70% VO2peak) acute exercise has also been shown to 
increase levels of salivary TGF-β among healthy adult males (n=10) [120]. Animal 
studies using diabetic mice have reported decreases in TGF-β  following moderate 
intensity exercise training;[121] however, limited research exists on the impact of 
exercise training among adults with asthma and to date, no study has examined the 
impact of HIIT on salivary levels of TGF- β in adults with asthma. Strenuous exercise 
has a greater impact on circulating levels of TGF-β when compared to moderate intensity 
exercise [122]. Given the importance of TGF-β in the asthmatic response , it is important 
to better understand the chronic response of HIIT on salivary levels of TGF-β among 
adults with asthma. 
Inflammation and Acute Exercise: Acute exercise has been shown to increase salivary 
levels of various pro- inflammatory cytokines such as TNF-a, IL-1β, and IL-8, and anti-




inflammatory cytokines such as IL-1Ra among adults both with and without asthma. 
Specifically, in a study of 10 physically active males (age: 23 ± 3years), a 60 minute 
exercise session was completed on a cycle ergometer at 75% of VO2max [91]. Saliva 
samples were obtained before exercise, immediately post, 60 minutes post, and 120 
minutes post-exercise. Levels of TNF-a, and IL-1β were significantly increased following 
the exercise session. The highest levels of TNF-a and  IL-1β were observed 60 minutes 
post exercise [91]. Similar results were observed in IL-6 levels in a study of 15 male 
athletes, who completed an exercise test consisting of 15 minutes of warm-up cycling 
followed by 25 minutes of isometric exercise (160 contractions of the knee) [123]. Saliva 
samples were obtained via the passive drool and salivette methods immediately before, 
immediately after, and 30, 60, 90, and 120 minutes post-exercise test. Salivary levels of 
IL-6 were significantly elevated immediately post-exercise, but did not remain 
significantly elevated 30 minutes post-exercise [123]. Among adults with EIBC, an 
increase in the aforementioned inflammatory markers may result in bronchoconstriction 
post-exercise[4]. Furthermore, it is likely that the levels of pro-inflammatory cytokines 
obtained from adults with EIBC would be higher than that among adults without EIBC, 
due to the inflammatory nature of the condition.  
Inflammation and Exercise Training: As opposed to acute exercise, exercise training 
reduces levels of systemic inflammation. Exercise training of continuous intensity 
improves airway inflammation among individuals with asthma as evidenced by 
reductions in fractional exhaled nitric oxide [124]. Similarly, exercise training of 
continuous intensity has been shown to reduce the expression of Th2 pro-inflammatory 
cytokines and increase the expression of IL-10 [125]. Reductions in pro-inflammatory 




cytokines have been reported among individuals with allergic rhinitis with aerobic 
exercise training as well. Specifically, reductions in serum concentrations of TNF-a and 
IL-4 were reported following exercise training, which consisted of 40-60 minutes of 
moderate intensity continuous exercise, performed 3-4 days per week, for 6 months [15]. 
Similar reductions in serum concentrations of TNF-a were reported following an 8-week 
endurance exercise program, which consisted of  running on a treadmill for 15-30 
minutes, at 50-70% of maximum heart rate among healthy sedentary men [126]. Local 
concentrations of TNF-a, IL-6, and IL-1β decreased following a six month endurance 
exercise training intervention among males with chronic heart failure [127]. The anti-
inflammatory properties of exercise have predominately been studied using moderate 
intensity continuous exercise training, with limited research available on the anti-
inflammatory properties of HIIT.  
Of the literature that is available, one study randomized 32 overweight/obese participants 
into three exercise conditions: 1) continuous exercise at 70% maximum heart rate 5 times 
per week, 2) HIIT sessions of 1x4 minutes at 90% maximum heart rate, and 3) 4x4 
minutes at 90% maximum heart rate [64]. HIIT sessions were completed 3 times per 
week for a total of 16 weeks. Serum levels of TNF-a, IL-6, and IL-10 were assessed at 
baseline and post-intervention. Results showed that HIIT reduced levels of IL-6 but 
increased TNF-a, while the continuous exercise reduced TNF-a among participants [64]. 
These results suggest that exercise training can elicit improvements in serum levels of 
inflammatory markers; however, less is known about whether HIIT can elicit 
improvements in the salivary levels of these markers. A better understanding of the 
impact of HIIT on pro and anti-inflammatory markers, assessed non-invasively, may 



















Hypothesis: It is hypothesized that a 6-week HIIT intervention will lead to reductions in 
salivary concentrations of pro-inflammatory markers TNF- α, IL-1β, IL-8, and CXCL10/IP-
10 and an increase in salivary concentrations of anti-inflammatory markers IL-1Ra and TGF-
β among adults with EIBC and healthy adults; however, adults with EIBC would experience 
greater improvements. Greater improvements among the EIBC group were expected based on 
literature that indicates adults with asthma generally have higher levels of these cytokines. 
Summary: Pro-inflammatory markers TNF-α, IL-8, and CXCL10/IP-10 have been shown to 
play an important role in the inflammatory cascade that occurs in response to acute exercise. 
Furthermore, these pro-inflammatory cytokines have been shown to play an integral role in 
bronchoconstriction. Circulating levels of IL-1Ra and TGF-β are responsive to acute exercise 
and increase as a result of exercise training. An increase in these anti-inflammatory cytokines 
may reduce the severity of EIBC by minimizing the pro-inflammatory effects.  
Research Gap: The inflammatory response to an acute bout of HIIT and to regular participation 
in HIIT among adults with asthma and healthy adults requires further investigation. To date, 
no study has assessed the inflammatory response to HIIT among adults with EIBC, or 
compared the differences in the inflammatory response to HIIT among adults with asthma and 
healthy adults. Positive results from this work may allow for improved exercise prescription 
(i.e. HIIT) among adults with asthma.   




2.7 FEV1, Ventilation, Exercise, and EIBC 
This next section outlines a review of the response of ventilation to acute exercise and 
how that triggers the inflammatory cascade outlined above, which ultimately reduces 
lung function, or FEV1, among adults with EIBC. For the purpose of this dissertation, the 
term pulmonary outcomes will be used to encompass all pulmonary data collected. 
As described in the preliminary sections of this dissertation, EIBC occurs due to 
evaporative water and heat loss from the lungs due to an increase in ventilation during 
exercise. This increase in ventilation is a normal physiological response to exercise and 
thus, occurs among adults with asthma and healthy adults. An increase in ventilation 
occurs as a result of an increase in breathing frequency (i.e. respiratory rate) and/or tidal 
volume (i.e. volume of air displaced between a normal inhalation and exhalation). 
Among healthy adults, the normal response of VT and RR is to increase as exercise 
intensity increases; however, during high intensity exercise the ventilatory efficiency (VE/ 
carbon dioxide output (VCO2)) is often reduced due to an excessive increase in 
respiratory rate [128]. 
Ventilatory efficiency describes the relationship between ventilation and VCO2 [129]. 
Among healthy adults, the most efficient lung is one where there is matching between 
ventilation to perfusion. When mismatching occurs, common among those with EIBC, 
the efficiency of the lung is reduced, which causes ventilation to increase for a given 
VCO2. To date, no study has examined the chronic impact of HIIT on pulmonary 
outcomes among adults with asthma or examined the perfusion of oxygen to the working 
muscles. It is possible that the intermittent recovery periods associated with HIIT may 




allow for intermittent recovery of respiratory rate and thus, ventilation. This may lead to 
less of a reduction in FEV1 post-exercise.  
Chronically, HIIT may improve cardiorespiratory fitness (VO2max) and ventilatory 
efficiency. Among adults with and without EIBC, VO2max is an important indicator of 
cardiorespiratory fitness and improvements in VO2max correlate with overall health. 
Additional benefits have been reported among adults with EIBC, in that improvements in 
VO2max correlate with improvements in asthma specific outcomes (i.e. asthma control) 
[14, 16]. Therefore, adherence to a 6-week HIIT intervention may lead to improvements 
in ventilatory variables during an acute bout of exercise, reducing the decline in FEV1 
post-exercise among adults with EIBC, and lead to improvements in VO2max, thus 
improving overall health among adults with and without EIBC and improving asthma-
specific outcomes among adults with EIBC. 
 
FEV1, Ventilation, and Acute Exercise:  
As mentioned above, limited research exists on the acute ventilatory response to HIIT. Of 
the literature that is available, such as the results from my Masters work, it appears that 
an acute bout of HIIT leads to a smaller reduction in FEV1 when compared to traditional 
continuous exercise among adults with EIBC [19].  Whether the ventilation patterns (i.e. 
VT, RR) between adults with and without EIBC differs during HIIT remains to be 
elucidated. Previous research suggests that when comparing the ventilation response 
during exercise between adults with and without EIBC, despite variations in lung 
function at baseline between adults with and without EIBC (i.e. adults with EIBC having 




a lower FEV1 at baseline and/or experiencing bronchoconstriction), the exercise 
ventilatory response is remarkably similar between groups [130]. In a study of 8 adults 
with mild asthma and 9 healthy adults, participants completed constant work-rate cycling 
to exhaustion following four separate interventions, consisting of the following: a control 
trial; inhalation of a fast-acting B2-agonist; eucapnic voluntary hyperpnea challenge; and 
sham to the hyperpnea. For each intervention, lung function was assessed pre and post-
intervention, and ventilation data during exercise were compared between the four 
interventions between groups. Results indicated that baseline FEV1 was significantly 
lower among adults with asthma when compared to adults without. Interestingly, despite 
variations in pre-exercise lung function, no differences were observed in ventilation 
during exercise between adults with and without asthma [130]. These findings suggest 
that despite the altered airway function associated with asthma, the ventilatory system 
during exercise among adults with and without EIBC appear to be similar.   
Although the majority of research has reported that EIBC occurs post-exercise, [19, 130] 
there is evidence to suggest that some adults experience EIBC during exercise [131, 132]. 
Specifically, in a study of 6 adults with asthma, participants completed a short exercise 
session (6 minutes) and a long exercise session (20 minutes), and lung function was 
assessed throughout each exercise session. A reduction in FEV1 during the long exercise 
session but not during the short exercise session was observed [131]. The reductions in 
FEV1 reported in the aforementioned study may be due to sustained high ventilations 
associated with continuous exercise. As such, the intermittent recovery periods that are 
associated with HIIT may allow for ventilation to recover intermittently, ultimately 




reducing the evaporative water and heat loss from the airways and thus, reducing the 
decline in FEV1 post-exercise. 
FEV1, Ventilation, and Exercise Training: Conflicting evidence exists regarding the 
effectiveness of exercise training to improve pulmonary function among adults with 
asthma. In a study of 36 individuals with asthma, participants were randomized into two 
groups as follows: an 8-week aerobic exercise group, and a control group of no exercise. 
Results showed an increase in FEV1, forced vital capacity, peak expiratory flow, and 
maximal voluntary ventilation following exercise training [133]. In contrast, following a 
12-week aerobic exercise training program among adults with asthma, no changes in 
pulmonary function as measured by FEV1, forced vital capacity, and FEV1 percent 
predicted were observed from pre to post-training [10]. Although no improvements in 
FEV1 post-exercise were observed, a trend towards significant improvements were 
reported in ventilatory efficiency (i.e. VE/VCO2). Furthermore, Cochrane reviews have 
consistently reported exercise training does not improve FEV1 among adults with asthma. 
The discrepancies in changes in FEV1 between studies may be due to improper 
spirometry technique and/or improvements in spirometry technique due to a learning 
effect. There are three key factors to consider in obtaining a valid and reliable measure 
[134]. These factors include the operator, the equipment, and the patient/participant. 
Those studies reporting contrasting evidence of improvements in FEV1 following 
exercise training may have included participants who were unskilled at spirometric 
maneuvers, who were uninterested in ensuring a maximal effort, or who improved based 
on practice from pre to post-intervention testing [134].  In order to reduce the impact of a 
training effect in participants who were included as part of this dissertation, 




familiarization, practice maneuvers, and video tutorials were sent to participants prior to 
attending the laboratory sessions.  
Of note, many adults with asthma experience hyperventilation [135], which may be due 
to anxiety surrounding the potential of experiencing an asthma attack [136]. 
Hyperventilation among adults with EIBC may lead to greater reductions in ventilatory 
efficiency and thus, increase the evaporative water and heat loss from the lungs, leading 
to a greater decline in FEV1. It is possible that a reduction in anxiety during before and/or 
during exercise (i.e. repeated exposure to feared stimuli or improvements in physical 
fitness) may aid in improving ventilatory efficiency, breathing frequency, tidal volume, 
and FEV1 post-exercise among adults with EIBC.  To date, the majority of research has 
focused on continuous exercise training; however, the impact of HIIT on VE, tidal 
volume, respiratory rate, and FEV1 is unclear. It is possible that repeated exposure to 
HIIT may reduce ventilation during acute exercise and thus, reduce post-exercise FEV1. 
Furthermore, reductions in inflammation as a result of reducing evaporative water and 







Summary: Among those with EIBC, FEV1 is generally lower at rest when compared 
to healthy adults, and decreases in response to an acute bout of exercise. Despite these 
differences, the ventilatory response to acute exercise is similar between those with 
asthma and healthy adults.  The bronchoconstriction associated with EIBC is triggered 
by the ventilation during acute exercise; however, the bronchoconstriction (i.e. decline 
in FEV1) generally occurs post-exercise. As such, the oxygen perfusion to the working 
muscle theoretically, should be similar between adults with asthma and healthy adults.  
 






















Research Gap: Although ventilation during exercise appears to be similar between 
adults with and without EIBC, the ventilatory response during HIIT has not been 
compared between these groups. Intermittent recovery periods associated with HIIT 
may for allow for ventilation (i.e respiratory rate and tidal volume) to recover 
intermittently, improving ventilatory efficiency and reducing the amount of water and 
heat loss from the lungs; thus, reducing the decline in FEV1 post-exercise. Chronic 
HIIT may further improve the ventilatory response by reducing hyperventilation due 
to improvements in fitness (i.e. VO2max) and in improvements in anxiety surrounding 
exercise and EIBC among adults with EIBC. If this is the case, HIIT may be a safer 
and more preferred form of exercise than traditional continuous exercise for adults with 
EIBC.  
 
Hypothesis: It is hypothesized that a 6-week HIIT intervention will improve post-
exercise FEV1, when exercising at the same absolute workload, among adults with 
EIBC. It is also hypothesized that improvements in fitness (i.e. VO2max) following 6-
weeks of HIIT, will lead to improvements in breathing frequency, tidal volume, and 
ventilatory efficiency among adults with and without EIBC. It is further hypothesized 
that adults with EIBC will have a more dynamic ventilatory response to HIIT when 
compared to adults without EIBC.    
 




2.8. VO2max, Heart Rate, Exercise, and EIBC 
Monitoring ventilation, RR, and VT during exercise is particularly important among 
adults with EIBC. In addition to providing a better understanding of the mechanisms 
responsible  (i.e. increases in RR and VT leading to airway cooling and dehydrating) for 
the decline in FEV1 post-exercise, monitoring ventilation during exercise also allows for 
the measurement of VO2max; an important indicator of the efficiency and effectiveness of 
the cardiorespiratory system to deliver oxygen to the working muscles among adults with 
and without EIBC [137]. During exercise, there is an increased requirement for oxygen 
from the working muscles, which leads to an increase in heart rate and to an increase in 
tissue oxygen saturation. Improvements in any and/or all outcomes of cardiorespiratory 
fitness can improve exercise performance [138-140]. 
VO2, Oxygen Saturation, Heart Rate, and Acute Exercise: During exercise, increases 
in VO2 and heart rate occur in response to the demand of exercise. Among adults with 
EIBC, ventilation does not appear to limit exercise performance [130]. Given that EIBC 
is a condition of the respiratory system, the cardiovascular response to exercise among 
those with and without EIBC should be similar. However, many adults with EIBC use 
bronchodilators prior to exercise in order to prevent the EIBC response. These inhaled 
bronchodilators increase heart rate and thus, may alter the cardiovascular response to 
exercise among adults with EIBC when compared to those without EIBC [141]. As well, 
the ventilatory limitations adults with EIBC may experience at rest (e.g. MVV) could 
reduce peripheral oxygen saturation during exercise when compared to adults without 
EIBC. Of the limited literature that is available, studies have reported that tissue oxygen 
saturation (TSI) does not differ during acute exercise (continuous) between adults with 




EIBC and healthy adults [142]. However, the TSI response to HIIT has not been 
examined between these groups.  
VO2, Oxygen Saturation, Heart Rate, and Exercise Training: HIIT is an effective 
form of exercise for improving VO2max [26]. In a meta-analysis, a mean increase of 0.51 
L-min-1 has been reported following HIIT of 6-13 weeks, with higher HIIT volumes 
resulting in greater improvements (0.8-0.9 L.min-1) in VO2max. [13]. Similar findings 
were reported in a systematic review and meta-analysis comparing HIIT to continuous 
exercise training among healthy adults. Results showed that HIIT elicited greater 
improvements in VO2max (5.5ml/kg/min ± 1.2 ml/kg/min) when compared to continuous 
exercise (1.2ml/kg/min ± 0.9ml/kg/min) [143]. Literature on the HIIT-mediated 
improvements in VO2max among adults with EIBC is sparse and as such, it is likely that 
the response between adults with EIBC and healthy adults would be similar. It is 
expected that adults with EIBC and healthy adults with a similar fitness level at baseline, 
would experience similar improvements in VO2max following a HIIT intervention.  
Among adults with EIBC, an increased heart rate may occur as a result of bronchodilator 
use; however, reduced need for bronchodilators following exercise participation has been 
observed. Therefore, it is possible that the cardiovascular profile during HIIT among 
adults with EIBC would not differ when compared to those without EIBC. Furthermore, 
it is expected that HIIT would lead to similar improvements in TSI between adults with 
EIBC and healthy adults due to the expected similar improvements in fitness.  
 
 












Summary: Exercise training improves parameters of cardiorespiratory fitness. Adults 
with EIBC may experience a higher heart rates and reduced tissue oxygen saturation 
when compared to healthy adults as a result of EIBC medication.  
Research Gap: To date, no study has examined the impact of a 6-week HIIT 
intervention between adults with EIBC and healthy adults on cardiorespiratory and 
cardiovascular outcomes. Therefore, it remains unclear as to whether the 
cardiovascular adaptations associated with HIIT among healthy adults would be 
similar among adults with EIBC. 
Hypothesis: It is hypothesized that adults with EIBC will exhibit a more dynamic heart 
rate response during exercise, as a result of medication use. It is further hypothesized 
that adults with EIBC will experience similar improvements in VO2max as healthy 
adults.  





2.9 Psychological Outcomes of EIBC  
As alluded to in the introduction, asthma and EIBC impact various domains of the 
individual including not only the physiological, but the psychological as well. 
Psychological variables play an important role in exercise participation and the exercise 
response among adults both with and without EIBC, and are often considered a barrier to 
regular exercise [144]. The psychological variables addressed in the current review and in 
this PhD work will focus on anxiety and enjoyment.  
 
Anxiety is a common problem among adults with asthma and may serve as a barrier to 
regular exercise, due to the fear of experiencing an asthma attack and/or asthma related 
symptoms. Exercise enjoyment is a strong predictor of future exercise engagement and 
thus, if exercise is not perceived as enjoyable there is a greater likelihood that adults will 
not participate in exercise. The section below discusses general anxiety and anxiety 
sensitivity among adults with and without EIBC and highlights their responses to acute 
and chronic exercise.  
 
General Anxiety & Anxiety Sensitivity 
Anxiety refers to a feeling of worry, nervousness, or unease about an event or about 
something with an unknown outcome. Among adults with asthma, anxiety is more 
prevalent when compared to those without [144]. One possible explanation for the higher 
prevalence of anxiety among adults with asthma may be due to unease around 
experiencing an asthma attack and the potential of an unknown outcome (i.e. medication 




needs, hospital admittance). General anxiety is a common health problem among young 
Canadians; approximately 12% of young Canadians have been reported to have been 
diagnosed with anxiety or an anxiety disorder [145]. Importantly, many adults with and 
without asthma have symptoms of anxiety that may interfere with their every lives, 
despite not having a clinical diagnosis of an anxiety disorder. Therefore, strategies to 
reduce symptoms of anxiety, such as exercise training, may have major implications in 
improving the lives of many Canadians with and without EIBC.  
Anxiety sensitivity differs from general anxiety in that anxiety sensitivity refers to fear 
related to anxiety sensations, such as an increase in heart rate, sweating, and difficulty 
breathing [146]. Research suggests that prevalence rates of anxiety sensitivity among 
adults with asthma ranges from 3.3 to 16% [147, 148]. This high prevalence of anxiety 
sensitivity among this population is of particular concern given that the presence of a 
psychiatric diagnosis, in particular panic-related psychopathology, is associated with poor 
asthma control [149, 150]. Furthermore, anxiety sensitivity may pose a significant 
problem for adults with EIBC given that sensations of anxiety sensitivity (i.e. increased 
heart rate, sweating) are also normal physiological responses to exercise. Therefore, 
adults with EIBC may experience heightened anxiety during exercise or at the thought of 
exercise due to the misinterpretation of normal physiological responses as an imminent 
threat. Heightened anxiety sensitivity often leads to avoidance of the feared stimuli (i.e. 
fear of physiological responses to exercise leads to the avoidance of exercise) [151], and 
the avoidance of exercise creates a multitude of health issues for adults with and without 
asthma. 




Anxiety and Acute Exercise: The aforementioned anxiety sensations are a normal 
physiological response to exercise; however, these responses pose a significant issue 
among those with greater levels of anxiety sensitivity. An inverse relationship between 
anxiety sensitivity and exercise participation has been reported due to avoidance of the 
physiological sensations of exercise, which may be interpreted as anxiety and panic 
related sensations [152]. Therefore, reducing levels of anxiety sensitivity may contribute 
to improving exercise participation rates by reducing anxiety-related barriers to regular 
exercise. 
Anxiety and Exercise Training: Fortunately, exercise training has been shown to 
improve anxiety sensitivity [16]. Improvements in anxiety sensitivity were observed 
following six 20-minute exercise sessions at 70% of maximum heart rate over a two week 
period [16]. Furthermore, the meaningful improvements observed in anxiety sensitivity 
tended to precede meaningful improvements in levels of general anxiety symptoms. The 
exact mechanisms responsible for the reductions in anxiety sensitivity observed following 
exercise training remains unclear; however, various theories purport to explain this 
improvement. For example, exposing someone with high anxiety sensitivity to the feared 
physiological sensations (i.e. increased heart rate), in the context of exercise can reduce 
their anxiety surrounding those sensations [152]. The exposure to the feared 
physiological sensations associated with exercise exemplifies to the individual, that 
although these sensations may be uncomfortable they do not pose a serious threat, and 
repeated exposure to exercise may facilitate habituation of the feared sensations [153, 
154].   




It is unknown as to whether the same improvements in anxiety sensitivity can be 
achieved through HIIT among adults with EIBC and healthy adults.  Anxiety sensitivity 
surrounding the feared physiological sensations associated with HIIT are expected to 
reduce over time, as a result of repeated exposure to the feared stimuli (i.e. HIIT). 
Reductions in anxiety sensitivity among adults with EIBC and healthy adults may serve 
to increase motivation to exercise as not only a means of improving physical health, but 
as an effective way to improve their psychological health. Taking into consideration the 
research suggesting that adults with asthma may have higher levels of anxiety [144], it is 
possible that a 6-week HIIT intervention will reduce general anxiety and anxiety 
sensitivity to a greater extent among adults with EIBC, given that they are more likely to 
experience higher anxiety and anxiety sensitivity at baseline. An acute bout of HIIT has 
been shown to preserve lung function; [19] therefore, chronic HIIT may reduce anxiety 
sensitivity to a greater extent among adults with EIBC, by not only exposing them to 
repeated HIIT, but by also allowing them to exercise without experiencing EIBC related 
symptoms (i.e. without experiencing feared EIBC related sensations).  
Summary: Adults with asthma are at an increased risk of developing an anxiety 
disorder. Among adults with and without asthma, elevated levels of anxiety and anxiety 
sensitivity may serve as a barrier to regular exercise; however, repeated exposure to 
anxiety provoking sensations through exercise training improves anxiety as well as 
anxiety sensitivity.  






Perceptual Feedback and Exercise Enjoyment 
Exercise participation rates remain suboptimal which may be in part, be due to exercise 
affect and/or exercise enjoyment. Among those with EIBC specifically, perceptions of 
dyspnea may contribute to an increase in perceptual levels of effort, affecting overall 
exercise enjoyment, and thus adherence to exercise.  
The Hedonic Theory refers to human motivation and suggests that humans are motivated 
to experience pleasure and avoid pain, which has great implications in the context of 
affect during exercise [155]. Specifically, the way one feels during exercise, or their 
Research Gap: Limited research exists on the anti-anxiety properties of HIIT among 
adults with and without EIBC. Given the prevalence of anxiety among adults with and 
without EIBC, non-pharmacological anxiety management or treatment tools such as 
HIIT, could have a major impact on the mental health of Canadian adults.  
Hypothesis: It is hypothesized that adults with EIBC will have higher levels of general 
anxiety and anxiety sensitivity when compared to adults without EIBC. Furthermore it is 
hypothesized that adults with EIBC will experience greater improvements in general 
anxiety and anxiety sensitivity when compared to adults without following a 6-week 
HIIT intervention. Lastly, it is hypothesized that adults with EIBC will experience a 
reduction in asthma specific exercise anxiety following a 6-week HIIT intervention, as a 
result of repeated exposure to HIIT and EICB symptoms.  




affective response to exercise, may have a predictive role in future exercise engagement, 
and play a role in exercise behavior [156]. Exercise intensity is an important contributor 
to exercise affect and overall exercise enjoyment. Specifically, a negative relationship 
exists between exercise intensity and affect. For example, as exercise intensity increases 
above ventilatory threshold, the affective response during exercise becomes more 
negative [157, 158]. In a study that sought to determine the affective response to vigorous 
intensity exercise (80% of VO2max for 30 minutes) and moderate intensity exercise (50% 
of VO2max), participants reported greater psychological distress and lower exercise 
enjoyment during the vigorous intensity exercise [157]. The dual-model theory has been 
proposed as an explanation of the negative relationship observed between exercise 
intensity and affect. According to this theory, affect experienced during exercise is partly 
influenced by metabolic cost associated with exercise intensity [159]. 
Interestingly, HIIT is associated with higher levels of exercise enjoyment when compared 
to moderate intensity continuous training [27, 160]. An acute bout of HIIT elicits a more 
positive mood and greater exercise enjoyment than an acute bout of moderate intensity 
continuous exercise among adults with EIBC [161, 162]. One possible explanation for the 
higher affect observed during HIIT among adults with EIBC, may be due to the 
intermittent recovery periods associated with HIIT. These intermittent recovery periods 
may allow adults with EIBC to intermittently reduce ventilation and thus, reduce water 
and heat loss from the airways, contributing to an attenuated EIBC response [4]. A 
second explanation that may be contributing to the higher affect during HIIT among 
adults with EIBC, may be related to the reduced time commitment associated with HIIT. 
Lack of time is consistently cited as the primary barrier to regular physical activity 




regardless of age, sex, or health status [163]. Therefore, the time-efficient nature of HIIT 
may lead to greater affect during exercise. The critical role exercise enjoyment plays in 
regular exercise participation requires further investigation in order to reduce barriers to 









2.10 EIBC Specific Variables and Exercise  
The following EIBC specific variables need to be taken into consideration when 
monitoring and prescribing exercise among this population in order to better understand 
the impact of exercise on this condition.  
Asthma Symptoms, Asthma Control & Asthma Related Quality of Life 
Dyspnea, or shortness of breath, is a common symptom among adults with asthma and a 
common response during exercise. Dyspnea has been shown to be a strong barrier to 
exercise participation and thus, adults with asthma often avoid exercise in an effort to 
avoid dyspnea [164]. The problem with this is that without exercise dyspnea becomes 
Research Gap: The affective and enjoyment response to chronic HIIT among adults 
with and without EIBC has not yet been determined.  
Hypothesis: It is hypothesized that affect during exercise and exercise enjoyment will 
improve following a 6-week HIIT intervention among adults with and without EIBC, 
with the greatest improvements being observed among adults with EIBC due to a 
reduction in EIBC symptoms during exercise. 




worse over time and eventually dyspnea occurs during activities of daily living. The 
frequency of dyspnea, as well as additional asthma symptoms such as coughing, 
wheezing, and chest tightness is used to determine asthma control [5].  Asthma control 
can range from completely controlled (experiencing no symptoms during any activity) to 
not at all controlled (experiencing symptoms all the time). Poor asthma control has been 
associated with a lower perception of health related quality of life [165]. Despite various 
treatment options, many individuals with asthma continue to report symptoms of poorly 
controlled asthma[166]. Poor asthma control can reduce quality of life and has been 
associated with an increased risk of developing anxiety, depression, and hyperventilation 
[7]. Therefore, reducing asthma symptoms (i.e. dyspnea) can lead to improvements in 
asthma control and as such, have major implications in the quality of life among adults 
with asthma.  
Asthma Control and Exercise Training: Exercise training has been shown to improve 
asthma control;[10] however, the mechanisms responsible for the improvements in 
asthma control are unknown. In a study of 18 adults with asthma, participants completed 
a 12-week aerobic exercise training program and experienced improvements in asthma 
control from pre to post- intervention, and these improvements were maintained 12-
weeks following the intervention. The improvements in asthma control were also 
accompanied by improvements in quality of life among participants [10]. Similar findings 
in improvements in quality of life were reported in a 16-week aerobic training 
intervention among children with asthma [167].  
Improvements in health related quality of life among adults with asthma following a 12-
week HIIT intervention (2 times per week for 40 minutes) [168] have been observed. 




These findings paired with the benefits of HIIT described above, illustrate that HIIT is a 
promising form of exercise among adults with EIBC. Unfortunately, limited research 
exists regarding the benefits of a low volume HIIT intervention among this population. 
The low volume HIIT intervention that was implemented within this dissertation lends 
itself to a more real-world application, in that many adults with and without EIBC 
perceive time as a significant barrier to exercise. Therefore, a HIIT intervention that 
offers a shorter time commitment than traditional exercise training may be more 
attractive among many adults. Furthermore, long-term compliance to exercise training is 
difficult to attain and thus, having a better understanding of the EIBC-specific 
adaptations that occur over 6-weeks of HIIT will provide valuable insight into exercise 










Summary: Exercise training has been associated with improvements in perceptions of 
dyspnea, asthma control, and health related quality of life among adults with asthma. 
 
Research Gap: To date, no study has examined the impact of a 6-week HIIT intervention 
on asthma control and quality of life among adults with EIBC.  
 
Hypothesis: It is hypothesized that adults with EIBC will experience improvements in 
asthma control and asthma related quality of life following a 6-week HIIT intervention as 
a result of improvements in fitness. 
 




2.11 Chapter Summary: 
In this chapter HIIT, the pathophysiology of asthma, treatment options for asthma and 
EIBC, and the impact of exercise on the inflammatory, ventilatory, cardiovascular, and 
psychological variables were described. By examining previous literature within these 
areas, it is clear that evidence surrounding the physiological, psychological, and clinical 
impact of HIIT among adults with EIBC and evidence is greatly lacking.  
The overarching goals outlined in Chapter 1 were sub-divided into four distinct research 
questions. The research questions outlined below were addressed by implementing a 6-
week high intensity interval training (HIIT) intervention and assessing outcomes pre (T1) 
and post (T2) intervention among adults with asthma and healthy controls.  
2.11 RESEARCH QUESTIONS:  
1. Does a 6-week HIIT intervention lead to a reduction in salivary concentrations of 
IL-8, TNF-a, IL-1β, and IP-10 and an increase in IL-1Ra and TGF- β from T1 to 
T2 among adults with and EIBC and healthy controls?  
2. Does a 6-week HIIT intervention alter the acute response in pulmonary outcomes 
among adults with EIBC and healthy controls? 
3. Does a 6-week HIIT intervention improve general anxiety, anxiety sensitivity, and 
asthma specific exercise anxiety among adults with EIBC? 
4. Does a 6-week HIIT intervention improve asthma control, perceptions of dyspnea, 
and exercise enjoyment, among adults with EIBC?  
The subsequent chapters of this dissertation have been organized to highlight the key 
findings for each research question outlined above.   




Chapter 3: The impact of HIIT on salivary markers of inflammation among adults with 
and without asthma 
  





TITLE: The Impact of HIIT on Salivary Markers of Inflammation among Adults with 










INTRODUCTION: The chronic airway inflammation associated with asthma occurs due 
to the release of a variety of cells, such as eosinophils, lymphocytes, and mast cells. 
Interleukin-8 (IL-8), IL-1beta (β) and interferon-gamma-inducible-protein (CXCL10/IP-
10)) are pro-inflammatory markers that contribute to the acute and chronic inflammation 
associated with asthma.  Exercise training reduces various pro-inflammatory markers and 
increases anti-inflammatory markers (e.g. interleukin-1 receptor antagonist (IL-1Ra)) in 
the serum; however, limited research exists on the impact of exercise training on reducing 
salivary levels of IL-8 and IL-1Ra among adults with asthma and healthy controls. 
METHODS: A 6-week exercise intervention was conducted among adults with asthma and 
healthy controls. Exercise-induced bronchoconstriction was confirmed using the eucapnic 
voluntary hyperpnea challenge. Saliva samples were collected at the beginning and end of 
the first (T1) and last (T2) exercise sessions. RESULTS: Independent samples t-test 
revealed a trend towards the asthma group (n=20) having higher levels of IL-8 at T1 
(Asthma: 0.2 ± 0.1 pg/ug protein; Control: 0.1 ± 0.1 pg/ug protein, p=0.07) when compared 
to the control group (n=12). Results from the ANCOVA revealed that adults with asthma 
had significantly lower levels of IL-1Ra at T2 when compared to healthy controls (F(11.7, 
1) p<0.01, hp
2 = 0.3). No between group differences in IL-8 were observed at T2. 
CONCLUSIONS: A 6-week exercise intervention does not lead to reductions in salivary 
levels of IL-8 in adults with EIBC and healthy adults; however, adults with EIBC 
experience a reduction in salivary levels of IL-1Ra. These findings suggest that HIIT may 
play an important role in reducing the IL-1β /IL-1Ra ratio that contributes to the chronic 
inflammation associated with EIBC.  







Approximately 8.1% of Canadians are living with asthma,  [169]characterized by chronic 
inflammation and acute bronchoconstriction [170]. The chronic airway inflammation 
associated with asthma results from various cells, such as eosinophils, lymphocytes, and 
mast cells [43, 44]. These inflammatory cells release inflammatory markers including 
cytokines, chemokines, and mediators (i.e. interleukin-8 (IL-8), IL-1beta (β), interferon-
gamma-inducible-protein (CXCL10/IP-10)) that contribute to local inflammation and 
systemic inflammation among adults with asthma [30, 44]. In order to combat this 
inflammatory cascade various anti-inflammatory cytokines are released and have been 
shown to play an important role in asthma, such as IL-1receptor antagonist (IL-1Ra) 
[117].  IL-1Ra is a specific inhibitor for IL-1 receptor pro-inflammatory cytokines and 
thus, plays an important role in combating the inflammatory response; unfortunately, 
adults with asthma have lower levels (assessed via serum) of IL-1Ra when compared to 
controls [117]. 
It has been suggested that the local lung inflammation associated with asthma contributes 
to an increase in systemic inflammation (e.g. higher levels of IL-8 and IL-1β)  [171]. 
Increased systemic inflammation among adults with asthma is evident by an increase in 
circulating pro-inflammatory cytokines and neutrophils [172, 173]. For example, IL-8 has 
been shown to be upregulated among adults with asthma and plays an important role in the 
inflammatory cascade associated with asthma [104]. Furthermore, higher levels of IL-8 
among adults with asthma has been associated with worse asthma control [105]. 




Investigating the impact of various treatment strategies that lead to reductions in local and 
systemic inflammation among adults with asthma is warranted.  
One such strategy that may serve to reduce local and systemic inflammation among adults 
with asthma may be through exercise training. Previous research has found that aerobic 
exercise can reduce inflammation among adults with asthma [109]. Specifically, following 
a 12-week intervention, adults with asthma in the exercise group experienced a greater 
reduction in serum levels of  cytokines interleukin-6 (IL-6) and monocyte chemoattractant 
protein-1 (MCP-1) when compared to the non-exercise control asthma group (n=23). 
Interestingly, the exercise group and non-exercise group did not experience a significantly 
different reduction in IL-8 from pre to post-intervention [109]. Serum IL-8 has been shown 
to be upregulated among adults with asthma [105] and as such, strategies to reduce IL-8 
levels may have important implications among this population. Among healthy adults, 
exercise training has been shown to increase plasma levels of anti-inflammatory cytokines, 
including IL-1Ra [116]. Unfortunately, less is known about the response of IL-1Ra to 
exercise training among adults with asthma.  
Despite the benefits of exercise training noted above, acute activity triggers exercise 
induced asthma (EIA) in approximately 90% of adults with asthma [3]. Higher levels of 
IL-8 among adults with asthma have been associated with worse asthma control (15) (i.e. 
increased coughing, wheezing, greater declines in forced expiratory volume in 1 second 
(FEV1)).  As such, it is possible that those with a more severe EVH response (i.e. greater 
decline in FEV1 following the challenge) may exhibit higher inflammation; however, this 
has yet to be determined.  




To date, the majority of literature on inflammation and exercise training has been assessed 
via invasive methods such as blood draws and as such, requires highly trained personnel 
and a willingness of participants to allow such invasive measures. In recent years, 
assessment of inflammation assessed non-invasively via saliva has grown in popularity 
[174].  
Thus, the purpose of this study was to determine if a 6-week exercise intervention would 
lead to a reduction in pro-inflammatory salivary markers of inflammation IL-8 and IL-1β, 
and anti-inflammatory marker IL-1Ra and CXCL10/IP-10. It was hypothesized that adults 
with asthma would experience greater reductions in IL-8 and IL-1β and greater increases 
in salivary concentrations of IL-1Ra following exercise training when compared to healthy 
adults, given the up-regulation of inflammation associated with asthma [105]. Secondly, it 
was hypothesized that adults with asthma who experienced the greatest reduction in FEV1 
following the EVH challenge would exhibit higher levels of pro-inflammation when 
compared to those with a smaller FEV1 decline [175, 176].  
METHODS 
Study Design 
A 6-week HIIT intervention using a quasi-experimental study design was conducted among 
adults with and without asthma. Adults with asthma and healthy controls completed a 6-
week high intensity interval training (HIIT) intervention, 3 times per week. Measurements 
were taken  pre-exercise and post-exercise  during the first HIIT (T1) and last HIIT (T2) 
sessions to determine the overall effect of the intervention as well as the the acute 
inflammatory response to exercise.  





Inclusion in the control group was limited to  adults aged 18-44 years, self-reported as 
moderately active, and non-smoking. Inclusion in the asthma group was further limited to 
those who had a self-report physician diagnosis of asthma, those with a current prescription 
for a short-acting bronchodilator, and to those who had a positive response to the EVH 
challenge (described elsewhere) [69]. All participants provided written informed consent 
prior to participation in the study. This study was approved by the Research Ethics Board 
at the University of Ontario Institute of Technology. 
Experimental Procedure 
Participants completed a maximal exercise test to determine baseline cardiorespiratory 
fitness and peak power output (PPO) to establish the workload of the HIIT protocols. A 
warm up at 25 Watts (W) for 4 minutes preceded the test, which included a ramp protocol 
in which the intensity increased by 1 W every 2 seconds, until volitional exhaustion. On a 
separate day, participants began the HIIT intervention consisting of a 4-minute warm up at 
25 W followed by 10% PPO for 1 minute, 90% PPO for 1 minute, repeated 10 times. 
Participants completed the training 3 times per week for 6-weeks. Following the 6-week 
intervention, participants completed a second maximal exercise test.  
Saliva Collection and Analysis  
Unstimulated whole saliva was collected via the passive drool method. Two saliva samples 
were collected at two time points. A sample was collected pre- and 15 minutes post-
exercise at T1 and T2 until the 2mL vial was full. Twenty-four hours prior to collection, 
participants were asked to refrain from consuming caffeinated beverages at least 4 hours 




prior to testing, and to refrain from consuming a heavy meal at least 2 hours prior to testing. 
Upon arrival to the laboratory, participants rinsed their mouths with water, in order to 
discard of any debris in the mouth. Saliva was then collected and samples were 
immediately stored at -80oC until analysis.   
Saliva samples were thawed and centrifuged for 15 minutes at 1500 x g to pellet mucins 
and other debris. Prior to cytokine analysis, total protein content within each saliva sample 
was determined using the Coomassie PLUS Protein Assay Reagent (Thermo Fisher 
Scientific, MA, USA). Levels of IL-8 (R&D Systems), IL-1Ra (R&D Systems, Catalog), 
and tumor necrosis factor (TNF) α (R&D Systems) were determined in both healthy and 
asthma groups, while levels of IL-1β (R&D Systems) and CXCL10/IP-10 (R&D Systems) 
were also determined in the asthma group using enzyme-linked immunosorbent assays 
(ELISA) following manufacturer’s protocols (R&D Systems, MN, USA).  IL-1β and 
CXCL10/IP-10 were assessed in the asthma group only due to funding restraints. ELISAs 
were processed in 96-well high-binding microplates (Greiner Bio-One, Frickenausen, 
Germany) and plates were read at a wavelength of 450 nm using a Synergy HTTR 
microplate reader (Bio-Tek Instrumentation, VT, USA). Cytokine data was standardized 
with the amount of total protein found within each saliva sample and expressed as pg/mL 
and pg/µg of protein.  
Statistical Analyses 
All data are presented as means and standard errors of the mean. Data were tested for 
normality using the Shapiro-Wilk test. IL-8, IL-1Ra, CXCL10/IP-10, and IL-1β 
concentrations were transformed for normality. Transformed data showed consistent 
results with the non-transformed data and as such, non-transformed data are reported. For 




some samples, cytokine concentrations were below the limit of quantification (LoQ). In 
such cases, the value was imputed using the following equation:  
Below Limit of Quantification (BLQ) = LOQ/√2 x dilution factor 
 An independent samples t-test was conducted to determine between group differences in 
IL-8 and IL-1Ra concentrations at T1. Analyses could not be conducted for the acute 
response to exercise at T1 and T2 due to insufficient data. A paired samples t-test was 
conducted to determine within group differences in IL-8 and IL-1Ra from T1 to T2. A 
one-way analysis of covariance (ANCOVA) was conducted to determine between group 
differences in IL-8 and IL-1RA at T2, while controlling for values of IL-8 and IL-1Ra at 
T1. Effect sizes were reported using partial eta squared (hp
2) values from the ANCOVA.  
Among the asthma group, a Pearson correlation was conducted to determine the 
relationship between the decline in FEV1 post-EVH to levels of IL-8, IL-1Ra, 
CXCL10/IP-10, and IL-1β at T1.  
All statistics were completed in IBM SPSS statistics 26.0 (Armonk, NY) and statistical 




Participants in the asthma group (n=20) had an average age of 22 years ± 3.3 and 11/20 
were female. Participants in the control group (n=12) had an average age of 21 years ± 1.9 
and 8/12 were female. Participants did not differ in height, weight, or VO2max. Participant 
characteristics are displayed in Table 1.  




TABLE 3.1 Participant Characteristics at T1  
 
 
Independent samples t-test revealed a trend towards the asthma group having higher 
levels of IL-8 at T1 (Asthma: 0.2 ± 0.1; Control: 0.1 ± 0.1, p=0.07).  
Chronic Response to Exercise 
Results from the ANCOVA revealed that adults with asthma had significantly lower levels 
of IL-1Ra at T2 when compared to healthy controls (F(11.7, 1) p<0.01, hp
2 = 0.3). No 
between group differences in IL-8 were observed at T2. Figures 1a-b illustrate between 
group differences in IL-8 and IL-1Ra concentrations at T1 and T2. 
Characteristic Asthma n=20 Healthy Control n=12 
M/F 9/11 4/8 
Age 22 ± 3.3 21 ± 2.0 
Height (cm) 169.5 ± 7.2 165.5 ± 8.1 




32.9 ± 8 34.5 ± 11.8 














No within group differences in IL-8 or IL-1Ra concentrations were observed among the healthy 
control group from T1 to T2.  
Within the asthma group, a significant reduction in IL-1Ra concentration (Asthma T1: 0.9 ± 
0.6pg/ug protein; Asthma T2: 0.2 ± 0.16pg/ug protein, p<0.01) and a significant reduction in IL-
1β concentration (Asthma T1: 0.05 ± 0.046pg/ug protein; Asthma T2: 0.01 ± 0.016pg/ug protein, 
p=0.01) was observed from T1 to T2. No within group differences in CXCL10/IP-10 from T1 to 
T2 were observed. Figures 2a-b illustrate changes in CXCL10/IP-10 and IL-1β concentrations 
among the asthma group from T1 to T2.  
 














Among the asthma group, a moderate positive correlation (r(18) = 0.33, p=0.1) was 
observed between FEV1 decline post-EVH and IL-8 at T1, suggesting greater 
bronchoconstriction following the EVH challenge was moderately positively correlated 
with higher levels of IL-8.  
Acute Response to Exercise 
Between group differences in the acute response in IL-8 and IL-1Ra could not be analyzed 
due to >50% of values were BLQ[177]. 
DISCUSSION 
The primary purpose of this study was to determine if a 6-week exercise intervention was 
effective in reducing salivary concentrations of the pro-inflammatory marker IL-8 and 
increasing salivary concentrations of the anti-inflammatory marker IL-1Ra among adults 
with asthma and healthy controls. Our primary finding is that, contrary to our hypothesis, 
no changes occurred in the salivary concentrations of IL-8 from T1 to T2 and that adults 
with asthma experience a decrease in salivary concentrations of the anti-inflammatory 
marker IL-1Ra from T1 to T2, while controls experienced no changes.  Our secondary 
finding is that the decline in FEV1 following the EVH challenge is moderately positively 
correlated with levels of IL-8.These findings suggest that HIIT may play an important 
role in the inflammatory profile of adults with asthma by improving the IL-1β /IL-1Ra 
ratio, despite no changes in IL-8.  
In the present study, salivary IL-8 concentrations did not change from T1 to T2 among 
adults with asthma and healthy controls. One possible explanation for the lack of change 
observed post-intervention in IL-8 may be related to the timing of which IL-8 was 




collected. Although all participants were instructed to provide a saliva sample 30 minutes 
post-exercise, saliva flow rate varied greatly among participants and as such, IL-8 levels 
could have been restored by the time the sample was collected. For example, an acute 
bout of high intensity exercise among adults with asthma (n=39) led to an increase 
plasma IL-8 immediately post-exercise but levels returned to baseline values 1 hour post-
exercise [108]. This suggests that the timing of assessment of IL-8 ay be key in 
understanding its’ response to acute and chronic exercise. The lack of changes in salivary 
markers of IL-8 following HIIT in the present study is in line with previous research that 
compared the impact of a 12-week continuous exercise program (twice per week) on 
serum levels of IL-8, in which no changes were observed between an asthma exercise and 
an asthma control group [109]. Participants in the study by Franca-Pinto and colleagues 
(2015) had moderate to severe asthma [109] whereas, participants in the present study 
had well-controlled asthma, suggesting that IL-8 may not be responsive to exercise 
training regardless of asthma control.  Future research is required in order to determine 
the optimal timing of IL-8 assessment in order to better understand the impact of exercise 
training on this cytokine.  
Contrary to our hypothesis, adults with asthma experienced a reduction in salivary 
concentrations of IL-1Ra following 6-weeks of exercise training. These findings differ 
from previous research reporting that in mouse models of asthma, aerobic exercise 
training leads to an increase in IL-1Ra expression in the bronchials [178]. Of note, our 
findings of a reduction in salivary IL-1Ra levels following exercise training may be 
related to the reduction observed in salivary IL-1β levels. IL-1β is elevated in the sputum 
of individuals with stable and exacerbating asthma [100] and the dysregulation between 




the IL-1β /IL-Ra ratio is important for the inflammation observed among adults with 
asthma [117]. As such, it is possible that a reduction in IL-1β following exercise training 
may explain the reduction in IL-1Ra given the dampened pro-inflammatory profile. Thus, 
exercise training may reduce levels of the pro-inflammatory marker IL-1β and in turn 
reduce levels of the anti-inflammatory marker IL-1Ra. Our data suggest that the response 
of salivary concentrations of IL-1Ra differ between adults with asthma and healthy adults 
and as such, future research should be conducted to determine the mechanisms 
responsible for this difference to better tailor treatment options for adults with asthma.  
. CXCL10/IP-10  increases the hyper-reactivity in the airways in asthma thus, options 
that may lead to a reduction in this cytokine are key in improving bronchoconstriction 
among adults with asthma [112]. This study is the first, to our knowledge, to determine 
the impact of exercise training on CXCL10/IP-10 among adults with asthma   Previous 
research among healthy adults (n=413) has reported that an 8-week aerobic exercise 
training program leads to a reduction in serum CXCL10/IP-10 [113]. These discrepancies 
may be due to a variety of factors. First, it may be that our study was too short to detect a 
difference in CXCL10/IP-10 (i.e. 6 weeks vs 8 weeks). Second, it could be that exercise 
training among adults with asthma may not have the same effect on salivary CXCL10/IP-
10 levels when compared to healthy controls. Discrepancies may also be due to the 
different methods of assessing CXCL10/IP-10 (i.e. serum vs saliva). The present study 
did not compare CXCL10/IP-10 between adults with asthma and healthy controls due to 
funding limitations and as such, we are unable to determine potential differences in 
CXCL10/IP-10 following exercise training between groups.  




Results of the present study should be interpreted in light of the following limitations. 
First, the optimal timing for assessing cytokines via the saliva varies among cytokines 
and as such, it is possible that our assessment time point of 30 minutes post-exercise may 
have not been optimal for some cytokines assessed. As well, saliva flow rate varies 
greatly among individuals which may have led to greater variability in timing of 
assessments and may explain why some cytokines were BLQ (e.g. cytokine levels had 
restored to normal by the time measurement was completed). , Second, the homogeneity 
of our sample in regards to age and asthma control limits the generalizability of our 
findings. Future research should aim to determine the impact of HIIT among adults with 
varying levels of asthma control and among adults of different ages. Finally, the lack of 
an asthma control group confines the generalizability of our findings. Future larger scale 
randomized control trials should be conducted in order to better understand the impact of 
exercise training among adults with asthma.  
In conclusion, it appears that a 6-week exercise intervention elicits a reduction in IL-1Ra 
among adults with asthma and elicits no changes in IL-8 among adults with asthma and 
healthy controls. Furthermore, it appears that the decline in FEV1 following the EVH 
challenge is associated with levels of IL-8 among adults with asthma and thus, may lend 
additional benefits to the EVH challenge. These findings provide novel insight into the 
impact of exercise training on salivary pro and anti-inflammatory cytokines among adults 
with asthma and healthy controls.  
 
  





Connecting Statement I 
In the previous chapter, we found that a 6-week HIIT intervention does not improve the 
salivary concentrations of IL-8 among adults with asthma or among healthy adults. 
Furthermore, we observed that adults with EIBC experience a reduction in the salivary 
concentrations of anti-inflammatory IL-1Ra.. The dysregulation of the IL-1β /IL-Ra ratio 
is an important contributor in the systemic inflammation observed among adults with 
asthma and our findings suggest that regulation of this ratio may be improved through 
HIIT.  The lack of changes in the salivary concentrations of IL-8 and may suggest that a 
6-week HIIT intervention is not long enough to see reductions in this cytokine. In the 
following chapter we analyze data related to the changes in ventilation that occur as a 
result of HIIT to further elucidate this possible relationship.    




Chapter 4: Comparing the pulmonary responses to high intensity interval training among 
adults with and without exercise induced bronchoconstriction 
  




Title: Comparing the pulmonary responses to high intensity interval training among 
adults with and without exercise induced bronchoconstriction 
 




















PURPOSE: To determine if the response of ventilation, respiratory rate (RR), tidal 
volume (VT), breathing reserve ((VE/MVVmax),  and peak tissue oxygen desaturation 
index (TSI) differs during maximal exercise pre (T1) and post (T2) a 6-week high 
intensity interval training (HIIT) intervention between adults with exercise induced 
bronchoconstriction (EIBC) and healthy adults. METHODS: A 6-week HIIT 
intervention was conducted. Participants completed a maximal exercise test at the 
beginning and end of the intervention to determine improvements in maximal oxygen 
consumption (VO2max), VEmax, RRmax, VTmax, (VE/MVVmax), and TSI. RESULTS: 
A total of 20 adults with EIBC (age: 21.4 ± 2.4) and 12 healthy controls (age: 22.5 ± 3.4), 
completed the 6-week HIIT intervention. Results from the one-way analysis of 
covariance (ANCOVA) revealed no improvements in VEmax, RRmax, VTmax, or 
VE/MVV among the asthma group from pre to post-intervention; whereas, the control 
group did experience such improvements. Adults with asthma had a higher RRmax 
(asthma: 49.8 ± 17.5, control: 42.9 ± 8.5, p=0.04) and VTmax (asthma: 2.4 ± 0.3 mL, 
control: 1.8 ± 0.5 mL, p=0.02) when compared to healthy adults at T1; however, these 
differences were no longer evident at T2. Adults with asthma did not experience 
improvements in VEmax, VTmax, RRmax, or peak TSI from T1 to T2; whereas, healthy 
adults experienced significant improvements in VEmax, VTmax, and RRmax, 
CONCLUSION: A 6-week HIIT intervention does not elicit improvements in ventilation 
among adults with asthma; however, healthy adults are able to improve the ventilation 
response following 6-weeks of HIIT.  
  





During aerobic exercise, ventilation (VE) increases in response to the increased 
requirement for oxygen (O2) and increased production of carbon dioxide (CO2). The 
increase in VE occurs as a result of an increase in respiratory rate (RR) and/or tidal 
volume (VT) [179]. In healthy, normal adults, VT and RR increase with increasing 
exercise intensity. At higher intensities of exercise, ventilatory efficiency (VE/ VCO2) is 
reduced due to greater increases in RR than VT. Many adults with asthma experience 
hyperventilation [135], which further increases RR leading to even greater reductions in 
ventilatory efficiency during exercise. Despite a reduction in efficiency, exercise 
performance is not typically limited by ventilation among adults with asthma [180].  
The breathing reserve (VE/maximal voluntary ventilation (MVV)), determined by 
assessing maximal ventilation during exercise (i.e. ventilatory demand) and maximal 
voluntary ventilation at rest (i.e. ventilatory capacity) is lower among those with 
obstructive lung conditions such as asthma [181]. Ventilatory demand is dependent on 
the metabolic demand of the exercise as well as individual differences (i.e. body weight, 
behavioural factors) [182]. Ventilatory capacity, is dependent upon mechanical factors 
such as airflow limitation, a common characteristic among adults with asthma [182]. As 
such, the lower breathing reserve observed among adults with obstructive lung conditions 
may be explained by the altered variable airflow limitation (i.e forced expiratory volume 
in 1 second (FEV1)) experienced at rest (i.e. ventilatory capacity) [183]. Among healthy 
adults, improvements in ventilatory capacity following 3 weeks of high intensity exercise 
have been observed [184] and among adults with asthma improvements in ventilatory 
capacity following a 10-week continuous exercise program have been observed 




[185].The impact HIIT on ventilatory capacity and breathing reserve between adults with 
asthma and healthy controls has not yet been determined.. It is possible that a higher 
exercise stimulus (e.g. high intensity intervals) may allow for improvements in 
ventilatory capacity among adults with asthma, similar to what has been observed in 
healthy adults [184].  
High intensity interval training (HIIT) is composed of brief bouts of high intensity 
activity followed by intermittent recovery periods and is well-tolerated among adults with 
asthma, as evidenced by a smaller reduction FEV1 pre and post-HIIT compared to 
continuous exercise [19]., The VE response to acute HIIT remains unclear and the 
adaptations associated with chronic HIIT among adults with asthma has not been 
determined. Various studies have reported that exercise training does not improve FEV1 
among adults with asthma [10, 186]; however the impact of chronic HIIT on VE, VT, RR, 
MVV, and ventilatory efficiency is unclear and could provide novel insight into the 
similarities and/or differences of the ventilatory profile between adults with asthma and 
healthy controls. It is possible that the high intensity nature of HIIT may result in a lower 
breathing reserve among adults with asthma acutely due to the intermittent recovery 
periods; however, as fitness improves (i.e. VO2max) through chronic training, VE, VT, 
RR, and the breathing reserve may also improve among adults with asthma.  
The high intensity nature of HIIT may allow for substantial improvements in fitness (i.e. 
VO2max) while experiencing less asthma related symptoms (e.g. reduced dyspnea) due to 
the intermittent recovery periods [162].  The primary purpose of this study was to 
determine if a 6-week HIIT intervention leads to improvements in ventilation (i.e. higher 
maximal ventilation) and its components (e.g. VT, RR) among adults with asthma when 




compared to healthy adults. It was hypothesized that adults with asthma would 
experience higher VE during acute exercise due to the likelihood of hyperventilation and 
that both groups would experience improvements in VE, VT, and RR from pre to post-
exercise training; however, healthy adults would experience greater improvements in 
VE/MVV (i.e. breathing reserve), due to the ventilatory limitations (i.e. MVV at baseline) 
associated with asthma. The secondary purpose of this study was to determine whether 
differences in ventilatory efficiency at baseline was associated with differences in tissue 
saturation in the periphery, and whether HIIT would lead to improved efficiency and thus 
improved tissue saturation acutely and chronically. It was hypothesized that adults with 
EIBC would exhibit lower tissue saturation due to lower ventilatory efficiency among 




A 6-week HIIT intervention using a quasi-experimental study design was conducted to 
compare changes in ventilatory measures of VEmax, VTmax, MVV, VE/MVV, and 
RRmax to HIIT at pre (T1) and post (T2) intervention between adults with asthma and 
healthy adults (control).  
Participants 
 Inclusion was limited to adults between the ages of 18-44 years, non-smokers, and those 
who were currently meeting the minimum physical activity guidelines of 150 minutes of 
moderate-vigorous intensity physical activity per week. For the asthma group, inclusion 
was further limited to those who had physician diagnosed asthma, a current prescription 




for a short-acting bronchodilator, and those who had a positive response to the eucapnic 
voluntary hyperpnea (EVH) challenge (described below).  Inclusion in the control group 
was limited to those who were free of any chronic conditions.  
All participants provided written informed consent prior to participation in the study. 
This study was approved by the Research Ethics Board at the University of Ontario 
Institute of Technology.  
Overview of Sessions 
Familiarization & Pre-Screening 
All participants who met the eligibility criteria were familiarized with hand-held 
spirometry, the head-set and mouthpiece, near infrared spectroscopy (NIRS) probe placed 
on each quadriceps muscle, and the cycle ergometer.  
Participants who self-reported having a physician diagnosis of asthma also completed the 
EVH challenge to confirm exercise induced bronchoconstriction. This procedure has 
been previously described [69]. Briefly, participants were asked to refrain from taking 
their short-acting bronchodilator 8 hours prior to the challenge. Upon arrival to the 
laboratory, participants completed three repeatable lung function measurements using a 
hand-held spirometer (EasyOne, Medizintechnik AG, Zurich, Switzerland) and the 
highest FEV1 value obtained was used to determine the target ventilation for the EVH 
challenge. Participants completed a single stage 6-minute challenge at a target ventilation 
of 25-30x FEV1. Participants inhaled room temperature dry air composed of 5% CO2, 
21% O2 and balance N2. Following the 6-minute challenge lung function was re-assessed 
in duplicate at 5, 10, 15, and 20 minutes post to determine the decline in FEV1. A positive 




response to the EVH challenge was considered as a 12% or greater decline in FEV1 from 
pre to post-EVH. The decline in EVH was calculated as follows: 
% Fall in FEV1 = 100 [FEV1 pre-challenge – FEV1 post-challenge] / FEV1 pre-challenge 
First and Last HIIT Sessions: During the first and last HIIT session participants were 
fitted with the headset, mouthpiece, and NIRS probe. Participants completed the exercise 
protocol (described below) and post-exercise measures of lung function using hand-held 
spirometry was assessed at minutes 5, 10, 15, and 20 to determine the decline in FEV1 
post-exercise. 
Maximal Exercise Test: Participants completed a ramp to maximal exercise test pre (T1) 
and post (T2) 6-week HIIT intervention. The protocol for the maximal exercise tests were 
as follows: 4-minute warm up at 25 W followed by a 1W per 2 second increase until 
volitional exhaustion. Peak power output was recorded as the final stage completed 
within the target RPM and was used to determine exercise intensity for the subsequent 
HIIT sessions as follows 90% PPO for 1 minute, 10% PPO for one minute, repeated 10 
times. HIIT sessions were completed 3 times per week for 6-weeks.  
Exercise Intervention 
Participants completed 6 weeks of HIIT; 3 times per week on a cycle ergometer. HIIT 
protocols were as follows: 5 minute warm-up at 25 Watts, followed by 10% peak power 
output for 1 minute, 90% peak power output for 1 minute, repeated 10 times.  
Lung Function: At the beginning of the first and last HIIT session, participants performed 
3 repeatable lung function assessments using a handheld spirometer (EasyOne 
diagnosotic spirometer, ndd Medizintechnik AG, Switzerland), according to the 




American Thoracic Society Guidelines (Miller et al., 2005). At minutes 5, 10, 15, and 20 
post-exercise spirometry was re-assessed in duplicate. The decline in FEV1 was 
calculated as follows: 
% Fall in FEV1 = 100 [FEV1 pre-challenge – FEV1 post-challenge] / FEV1 pre-challenge 
The highest FEV1 value at each time point post-exercise was used to determine FEV1 
decline. The maximum decline following exercise were used for statistical analysis. 
Maximal voluntary ventilation (MVV) was determined using the following equation: 
[182, 187, 188] 
MVV = FEV1 baseline x 40 
 
Ventilatory measures: Upon arrival to the laboratory, height and weight were assessed 
using a standardized medical scale (Detecto, USA), and resting heart rate and blood 
pressure were assessed following a 5-minute rest period. Baseline lung function was 
assessed using spirometry. Participants in the EIBC group were permitted to take to puffs 
of their short-acting bronchodilator and lung function was re-assessed 15-minutes post 
medication to determine reversibility. Reversibility was defined as > 12% and 200mL 
increase in FEV1 from baseline[66].  FEV1 % predicted was calculated using the 
following formula:  
FEV1% predicted = Race * 1.08 * ((0.043 * height) – (0.029 * age) – 2.49). 
Expired gas was collected through a pneumotachograph and analyzed using an automated 
gas collection system (Parvo Medics 2400, USA). Breath by breath values ventilation 




(VE), tidal volume (VT), respiratory rate (RR), volume of exhaled carbon dioxide (VCO2), 
and maximal oxygen consumption (VO2max) were analyzed. All ventialtory parameters 
were calculated by averaged the 5 breaths surrounding each point. The values at these 
points were used for statistical analysis.  
Tissue Oxygen Saturation (TSI): 
A two-wavelength (745 and 855nm), continuous wave NIRS system using spatially 
resolved spectrocscopy was used to measure tissue saturation (TSI) (Oxymon MK III, 
The Netherlands). TSI was monitored continuously throughout each maximal exercise 
test and the first and last exercise sessions. The NIRS probe was secured over the muscle 
belly of the vastus lateralis muscle, 12cm from the knee joint, along the vertical axis of 
the thigh. Data was sampled at 50 Hx and then down sampled to yield second-by-second 
data. The distance between the transmitter and received was set at 4.0 cm. The 
background and additional details of NIRS is described elsewhere [189].  
TSI provides an indication of oxygen saturation in the tissue by representing a ratio of 
oxygenated hemoglobin to total hemoglobin. TSI values were normalized for each 
participant to the average of the 30 to 60 seconds prior to the start of exercise during 
warn-up. For statistical purposes, this baseline value represented 100%. Peak desaturation 
was determined as the lowest 5 second period of TSI at the end of the first high intensity 
interval was used as 0% so that changes could be observed across intervals and 
compared. TSI peak desaturation was used for statistical analysis. 
Statistical Analysis 




Means and standard deviations were used to describe the sample. Independent samples t-
test were conducted to determine differences in baseline (T1) characteristics. Paired 
samples t-test were conducted to determine within group differences from T1 to T2.  A 
one-way analysis of covariance (ANCOVA) was conducted to determine differences 
between groups and sexes at T2 while controlling for differences at T1 for FEV1, 
VO2max, VEmax, RRmax, VTmax, VE/MVV, and peak TSI. An ANCOVA was also used 
to determine differences during acute exercise during each minute of HIIT session 18, 
while controlling for each minute of HIIT session 1 (i.e. baseline) measures of each 
outcome. Effect sizes were reported using partial eta squared (hp
2) values from the 
ANCOVA.  
All statistics were completed in IBM SPSS statistics 26.0 (Armonk, NY) and statistical 
significance was declared at p<0.05. 
Sample Size 
GPOWER statistical software indicated that in order to detect a significant improvement 
in VEmax from pre to post-intervention, using a medium effect size (0.5) with an alpha of 
0.05 and a power of 0.95, 16 participants would be required for this study.  
 
RESULTS 
A total of 20 adults with asthma and 12 healthy adults completed the 6-week HIIT 
intervention. Groups did not differ on age (asthma: 21.4 ± 2.4, control: 22.5 ± 3.4, p=0.4), 
height (asthma: 169.5 ± 7.1, control: 165.5 ± 8.0, p=0.1), weight (asthma: 73.8 ± 12.8, 
control: 69.7 ± 11.9, p=0.3), or VO2max (asthma: 32.9 ml/kg/min ± 8.0, control: 38.6 




ml/kg/min ± 8.2, p=0.6) at T1. Adults with asthma had a higher RRmax (asthma: 49.8 ± 
17.5, control: 42.9 ± 8.5, p=0.04) and VTmax (asthma: 2.4 ± 0.3 mL, control: 1.8 ± 0.5 
mL, p=0.02) when compared to healthy adults at T1. . 
Both groups experienced a significant improvement in VO2max from T1 (Asthma: 32.9 ± 
8ml/kg/min; Control: 34.5 ± 11.8ml/kg/min) to T2 (Asthma: 38.6 ± 8.2, p<0.01; Control: 
38.9 ± 12.3, p<0.01). Adults with asthma did not experience improvements in VEmax, 
VTmax, RRmax, or peak TSI from T1 to T2. Healthy adults experienced significant 
improvements in VEmax, VTmax, and RRmax, see Table 1. Additional within and 





























Age (years) 22.5 ± 3.2 22.5 ± 3.2 21.1 ± 1.9 21.1 ± 1.9 p=0.7 
Males/Females 9/11 9/11 4/8 4/8  
Height (cm) 169 ± 7.2 169 ± 7.2 165.5 ± 8.1   165.5 ± 8.1   p=0.4 
Weight (kg) 73.8 ± 12.8  74.0 ± 
13.1 
69.9 ± 11.7 68.9 ± 11.4 p=0.9 
Resting Heart 
Rate (bpm) 
79.1 ± 13.6 81 ± 13.4 81 ± 11.9 77.5 ± 12.3  p=0.4 
Forced 
Expiratory 
Volume in 1 
Second 
3.6 ± 0.6 3.1 ± 0.7 3.5 ± 0.7 3.3 ± 1.2  p=0.4 
Forced 
Expiratory 
Volume in 1 
Second Percent 
Predicted (%) 
85.5 ± 6.7 85.1 ± 6.1 86.6 ± 7.9 85.6 ± 6.4 p=0.3 
Forced Vital 
Capacity (L) 














32.9 ± 8 38.6 ± 
8.2† 
34.5 ± 11.8 38.9 ± 12.3† p=0.8 
Ventilation 
Maximum 
97.8 ± 22.2 108.7 ± 
29.5 





49.8 ± 17.5 47.5 ± 
10.3 
42.9 ± 8.5* 55.3 ± 6.4 † p=0.04 
Tidal Volume 
Maximum (mL) 
2.4 ± 0.3 2.6 ± 1.0 1.8 ± 0.5* 2.5 ± 0.6† p=0.02 




*p<0.05 between EIBC and control 
†p<0.05 within group from T1 to T2 
 
Maximal Exercise Response 
No between group differences were observed in VO2max (F(0.5, 1) p=0.8, hp
2 <0.01)), 
VEmax (F(0.0,1) p=0.9, hp
2 <0.01)), VTmax (F(0.7, 1) p=0.3, hp
2 = 0.02), RRmax (F(7.4, 
1) p=0.07, hp
2 0.1), or peak TSI (F(1.7, 1) p=0.7, hp
2 = 0.04) at T2. Figure 1(a-d) depicts 




0.67 ± 0.2 0.64 ± 0.1 0.62 ± 0.1 0.74 ± 0.1 p=0.1 




Figure 2.1a-c: Ventilation Maximum Pre and Post-Intervention 
    




Figure 2.2 a-c: Tidal Volume Maximum Pre and Post-Intervention 




Figure 2.3a-c: Respiratory Rate Maximum Pre and Post-Intervention 
 
 




Acute Exercise Response 
No differences were observed when comparing VEmax (F(0.2,1) p=0.6, hp
2  = <0.01)), 
VTmax (F(0.4, 1) p=0.7, hp
2 = 0.02)), RRmax (F(1.4, 1) p=0.09, hp
2 = 0.04), or peak TSI 
(F(0.4, 1) p=0.9 hp
2 = <0.01)) during acute exercise at T1 or T2 when comparing groups. 
Figures 2(a-c) illustrates the ventilatory pattern during acute HIIT between adults with 
asthma and healthy controls.  
 
DISCUSSION 
The primary finding of this study, in contrast to our hypothesis, was that adults with 
asthma did not experience significant improvements in VEmax, VTmax, MVV, VE/MVV, 
and RRmax following a 6-week HIIT intervention, whereas control participants did 
experience improvements. Our secondary finding is that RRmax during maximal exercise 
was higher among adults with asthma when compared to healthy adults at T1; however, 
following training, adults with asthma and healthy adults exhibit similar RRmax during 
maximal exercise. 
In line with our hypothesis, healthy adults experienced improvements in VEmax, VTmax, 
and RRmax following HIIT; however, contrary to our hypothesis, adults with asthma did 
not experience improvements. Previous research among healthy adults (n=72) reported 
similar improvements following 3-weeks of high intensity exercise [184]. Among adults 
with asthma, following 10-weeks of continuous exercise training no changes in VEmax, 
VTmax, or RRmax was observed; however significant improvements were observed in 
VE/MVV [185], which differs from the present findings. The discrepancies in VE/MVV 




observed between the two studies may be related to the duration of exercise training. It is 
possible that a longer (i.e. 10-week) HIIT intervention may lead to improvements in 
VE/MVV by increasing the volume of exercise training. Despite the improvements 
observed in VEmax, VTmax, and RRmax within the healthy control group in the present 
study, the ventilatory responses to exercise following HIIT did not differ between groups. 
This aligns with previous research examining the impact of continuous exercise training 
between adults with asthma and healthy adults. Specifically, in a study of eight adults 
with mild asthma and nine healthy controls, the ventilation response to constant work rate 
cycling (70%) was remarkably similar between groups, despite differences in baseline 
lung function [190]. Therefore, it appears that adults with asthma are able to meet the 
acute exercise requirements in increased ventilation during acute maximal exercise; 
however, that exercise training may not be able to improve indices of ventilation.  
In line with our hypothesis, we observed that adults with asthma had a higher RRmax at 
baseline when compared to healthy adults. This finding adds to the evidence that adults 
with asthma experience hyperventilation [135]; however, differs from previous research 
examining the impact of exercise training among adults with asthma. Specifically, in a 
study consisting of 5 adults with mild asthma and 5 controls participants completed a 10-
week aerobic conditioning program [185]. No differences in RR at baseline were 
observed between the two groups; however, although not significantly different, the 
asthma group did have a higher RR at VO2max (asthma RR: 34.6 ± 6.6; control RR: 32.4 
± 8.8) [185]. One possible explanation for the differences observed between the current 
study and the study described above may be in relation to sample size. The current study 
had a larger sample size and thus, it is possible that the study by Hallstrand and 




colleagues was not sufficiently powered to determine differences in RRmax between 
groups [185]. Furthermore, participants in the present study were screened for exercise 
induced bronchoconstriction whereas, participants (4/5) in the study by Hallstrand and 
colleagues self-reported a history of exercise induced bronchoconstriction. As such, it is 
possible that not all participants in the study by Hallstrand and collegaues had exercise 
induced bronchoconstriction and thus, perhaps differences in RR exist between those 
with asthma versus those with asthma and confirmed exercise induced 
bronchoconstriction. Future research should be conducted to determine if such 
differences exist.  
Contrary to our hypothesis, no differences in TSI desaturation were observed between 
groups; however, given the lack of differences observed in ventilation during exercise 
between groups this finding is not surprising. These findings are in line with previous 
research examining the TSI desaturation among adults with asthma and healthy controls 
during sprint interval exercise [191]. No differences in TSI desaturation were observed 
between adults with EIBC (n=8) and healthy controls (n=8) during 4x30 second bouts of 
sprint interval exercise interspersed with 4.5 minutes of active recovery [191]. In 
contrast, differences in TSI desaturation have been observed in a study among male 
cyclists (n=10) who completed six 30 second sprint interval bouts interspersed with 2 
minutes of recovery [192]. The lack of differences in TSI desaturation observed in the 
current study and the study by Good et al. (2019) may be explained by differences in 
intensity and recovery periods. For example, the present study had participants complete 
1-minute bouts of 90% PPO versus sprint intervals. The short recovery period in the 




study by Buchheit et al., (2012) following such intense exercise may suggest that oxygen 
delivery limitations may be related to intensity and recovery time.  
Our findings of a significant improvement in VO2max among adults with EIBC is similar 
to what has been reported in previous literature surrounding exercise interventions among 
adults with asthma. Specifically, in a study examining the impact of a 3-month exercise 
intervention at an intensity between 60-80%, twice weekly, an improvement in VO2max 
of 3.5% was observed [109]. Similarly, in a 12-week supervised aerobic exercise 
intervention among adults with asthma a 9.5% improvement in VO2max was reported 
[10]. Limited research has sought to determine the impact of HIIT among adults with 
asthma; however, of the literature that is available in an 8-week HIIT intervention among 
29 adults with asthma an 8.5% improvement in VO2max was observed. As such, our 
findings add to the literature that HIIT is an effective form of training to improve fitness 
among adults with EIBC, and these improvements are similar as to what is observed 
among healthy adults.  
Results from the current study should be interpreted in light of the following limitations. 
First, adults with asthma in the current study had mild and well-controlled asthma, 
according to the asthma control questionnaire [193]. As such, future research should aim 
to determine the pulmonary responses to HIIT among adults with severe and less 
controlled asthma, in order to better understand its’ impact among this population. 
Second, all participants in the current study were young adults and as such, it remains 
unclear as to whether middle-aged or older adults with and without asthma would 
experience similar improvements in the pulmonary responses to HIIT. 




In conclusion, it appears that a 6-week HIIT intervention does not lead to improvements 
in VEmax, MVV, VTmax, VE/MVV, and RRmax among adults with asthma; however, the 
pulmonary response to maximal exercise remains similar between adults with asthma and 
healthy controls following HIIT training. Future research should aim to determine the 
optimal mode of exercise and exercise intensity for improving pulmonary responses 
among adults with asthma.  
  




Connecting Statement II 
As described by previous research, high ventilation during exercise has been suggested as 
the root cause for acute bronchoconstriction (i.e. acute inflammatory response) due to 
evaporative water and heat loss from the airways [4]. Our findings suggest that adults 
with EIBC are able to meet the acute demands of exercise, similar to healthy adults; 
however, adults with EIBC do not experience improvements in ventilatory outcomes 
following exercise training in contrast to their healthy counterparts. Despite this, at the 
same absolute workload, following exercise training, adults with EIBC experience a 
reduction in RR and thus, ventilation. As such, it is possible that a reduction in RR may 
reduce the perceptions of dyspnea experienced as well as reduce the EIBC related 
symptoms (due to a reduction in evaporative water and heat loss) thus, reducing asthma 
and exercise related anxiety. Repeated exposure to high ventilations during exercise may 
serve to reduce anxiety and thus, reduce hyperventilation. The following chapter 
examines the impact of the 6-week HIIT intervention on anxiety and anxiety sensitivity 
among adults with and without asthma.  
  




Chapter 5: Reducing anxiety and anxiety sensitivity with high intensity interval training 
in adults with asthma 
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Low and moderate intensity exercise training has been shown to be effective for reducing 
general anxiety and anxiety sensitivity among adults with asthma. Exercise frequency and 
intensity have been shown to play an integral role in reducing anxiety sensitivity, 
however less is known about the impact of high intensity interval training (HIIT) on 
anxiety in adults with asthma. METHODS: A six week HIIT intervention was conducted 
with adults with asthma. Participants completed 6 weeks of HIIT (10% peak power 
output (PPO) for 1 minute, 90% PPO for 1 minute, repeated 10 times); 3 times per week 
on a cycle ergometer. Pre and post-intervention assessments included the Anxiety 
Sensitivity Index-3 (ASI) and the Body Sensations Questionnaire (BSQ). RESULTS: 
Participants (n=20) were 22.5 ± 3.2 years and 11 of 20 were female. Total ASI improved 
from pre to post-intervention (PRE: 17.9 ± 11.8; POST 12.4 ± 13, p = 0.002, Cohens d = 
0.4). BSQ improved from pre to post intervention (PRE: 2.4 ± 1.0; POST: 2.0 ± 0.8, 
p=0.007, Cohens d = 0.3). CONCLUSION: A 6-week HIIT intervention leads to 
improved anxiety among adults with asthma. Future research should determine the 
impact of HIIT among adults with asthma with clinical anxiety.  





General anxiety refers to a feeling of worry, nervousness, or unease about an event or 
something with an unknown outcome. Among adults with asthma, exercise participation 
may elicit feelings of anxiety for fear of an unknown outcome such as experiencing 
shortness of breath or wheezing. Anxiety sensitivity on the other hand refers to the fearful 
belief that bodily sensations such as breathlessness, wheezing, and an increased heart rate 
will lead to a negative social, physical, or cognitive consequence [146]. Adults with 
asthma experience these same symptoms during an acute asthma attack, or to a lesser 
extent, following an exercise session [3]. Furthermore, many of the feared bodily 
sensations associated with anxiety sensitivity are normal physiological responses to 
exercise [194]. Thus adults with asthma may misinterpret normal physiological responses 
to exercise as an imminent threat of an asthma attack and may experience heighted 
anxiety at the thought of exercise. 
Low and moderate intensity exercise training has been shown to be effective in reducing 
general anxiety among adults with asthma [195, 196]. Limited research exists on the 
impact of high intensity interval training (HIIT) on reducing general anxiety, anxiety 
sensitivity (i.e. worry about experiencing anxiety related sensations) and asthma specific 
exercise anxiety among adults with asthma. This is important because HIIT is composed 
of brief bouts of high intensity activity followed by intermittent recovery periods, as 
such, high intensity intervals require high ventilation rates whereas the low intervals 
allow for ventilation to recover intermittently. This pattern of exercise and ventilation 
may allow for asthma and anxiety symptoms to recover intermittently. A 10-week HIIT 
intervention in an indoor swimming pool (exercise training twice per week at 80-90% 




heart rate max for 2 minutes, followed by 1.5 minutes recovery of “mild” exercise) 
revealed that adults with exercise induced asthma were less afraid of experiencing 
breathlessness during exercise and less anxious about exercise following training [197]. 
Of note, the recovery intervals were only described as “mild” and swimming is unique in 
the heart rate and ventilation response to exercise [197]. There exists a gap therefore in 
the literature pertaining to HIIT and anxiety in adults with asthma that needs to be 
addressed to better prescribe exercise in this population.    
With regards to anxiety sensitivity, exercise frequency is positively correlated with 
anxiety sensitivity such that greater exercise frequency is associated with lower anxiety 
sensitivity among healthy adults (n=955) [198]. As well, exercise intensity has been 
shown to play an integral role in reducing anxiety sensitivity. In a study assessing the 
impact of exercise training on anxiety, participants with high anxiety sensitivity (>25 
total ASI) (n=77) completed five sessions of either moderate or low intensity exercise 
(70% and 30% of maximal oxygen uptake, respectively). Significant improvements were 
observed in anxiety pertaining to the fear of bodily sensations assessed using the Body 
Sensations Questionnaire (BSQ); greater improvements were observed among those in 
the moderate intensity group [199]. High intensity continuous aerobic activity has been 
shown to improve anxiety sensitivity and fear of anxiety-related physiological sensations 
to a greater extent than traditional low intensity exercise, in a short period of time among 
those with elevated anxiety sensitivity [200]. Less is known about the effect of HIIT on 
anxiety sensitivity. Among adults with asthma who are physically active (i.e. meeting the 
current physical activity guidelines) increasing the frequency and intensity of exercise 
through a HIIT intervention may result in improvements in anxiety sensitivity by 




repeatedly exposing adults with asthma to anxiety-related physiological sensations, but 
providing intermittent recovery.  
It is important to note that there may be gender differences in the types of anxiety [201]; 
however, conflicting research exists [202]. For example, some studies have reported that 
women generally experience greater anxiety related to physical concerns when compared 
to men. These differences have been observed by assessing the physical concern sub-
component of  the widely used Anxiety Sensitivity Index (PC-ASI) [201]. Gender 
differences observed in the improvements in anxiety sensitivity are thought to be due to 
differences in the physiological adaptations that contribute to physical discomfort during 
and after exercise in response to exercise training [203]. Therefore, women with asthma 
may experience greater discomfort during exercise when compared to men and thus, have 
greater anxiety sensitivity to those symptoms during exercise. Interestingly, other studies 
have reported no gender differences following a 2-week moderate to high exercise 
intervention [202]. Improvements in anxiety sensitivity following exercise training 
among both men and women have largely been attributed to the exposure theory (i.e. 
repeated exposure to a feared stimuli reduces the fear of that stimulus) [204] therefore, 
repeated exposure to HIIT, and the accompanying normal physiological responses may 
reduce anxiety sensitivity surrounding exercise participation among adults with asthma.  
Although exercise has been shown to improve anxiety among those with a clinical 
diagnosis [199], less research has focused on its’ impact in non-clinical populations. A 
2015 meta-analysis of 306 studies examining the role of regular exercise on reducing 
anxiety symptoms, revealed that regular exercise elicits a small effect on reducing 
anxiety symptoms among non-clinical populations [205]. Improving anxiety symptoms 




among those with non-clinical levels of anxiety adds to the therapeutic evidence of 
regular exercise among the general population. Among those with non-clinical anxiety 
and an asthma diagnosis, the relationship between anxiety and exercise is further 
convoluted. Given that HIIT allows for intermittent recovery, it may be a promising 
intervention for those with asthma. The primary purpose of this study was to determine 
whether a 6-week HIIT intervention would lead to improvements in general anxiety, 
anxiety sensitivity, and asthma-specific exercise anxiety among adults with asthma. The 
secondary purpose of this study was to determine whether gender impacts improvement 
in general, anxiety sensitivity, and asthma specific exercise anxiety following a 6-week 
HIIT intervention among adults with asthma. Based on the literature available, we 
hypothesized that participating in HIIT would lead to reductions in general anxiety, 
anxiety sensitivity and asthma-specific anxiety as a result of chronic exposure to HIIT 
[200]. Furthermore, it was hypothesized that women would experience greater reductions 
in anxiety surrounding physical concerns when compared to men [201].   
METHODS 
Study Design & Protocol 
A one-group pretest – posttest study design was used. Participants completed 6 weeks of 
HIIT; 3 times per week on a cycle ergometer (LODE Excaliber, Lode B.V., Netherlands 
or Monark Ergomedic 894E, Monark Exercise AB, Poland). HIIT protocols were as 
follows: 5 minute warm-up at 25 Watts, followed by 10% peak power output for 1 
minute, 90% peak power output for 1 minute, repeated 10 times. Participants completed a 
maximal exercise test at the beginning of the intervention to determine intensity for the 
exercise sessions. 





Participants were eligible for the study if they were between the ages of 18-44 years, self-
reported currently meeting the physical activity recommendations of 150 minutes of 
moderate-vigorous intensity physical activity per week, had a self-reported physician 
diagnosis of asthma, a current prescription for a short-acting bronchodilator, a positive 
response (>12% decline in forced expiratory volume in 1 second from pre to post-
challenge) to the eucapnic voluntary hyperpnea challenge, described elsewhere [69], and 
to those without a self-reported diagnosis of any mental health condition. 
Methodology 
Participants completed a series of questionnaires (described below) pertaining to general 
and asthma-specific anxiety at the beginning and end of the 6 week exercise intervention. 
Anxiety 
The ASI is a 16-item questionnaire used to determine the degree of worry surrounding 
anxiety-related sensations would lead to a negative social, physical, or cognitive 
consequence. Worry has been described as a cognitive process that serves an avoidant 
function used as a strategy to avoid or reduce internal distress [206]. Items on the ASI are 
scored on a 5-point likert scale ranging from 0 = very little to 4 = very distressing. The 
ASI assesses feelings of distress in three components 1) Physical Concerns (ASI-PC) (i.e. 
“It scares me when my heart beats rapidly”), 2) Cognitive Concerns (ASI-CC) (i.e. 
“When I can’t keep my mind on task, I worry I might be going crazy”), and 3) Social 
Concerns (ASI-SC) (i.e “It is important for me not to appear nervous”). Based on 
previous work, ASI scores can be classified as low (<17), moderate-high (17-23), and 




high AS (>23) [207]. The ASI has been shown to have high internal consistency [a 
ranging from 0.8 to 0.9][208], good retest reliability (r ranging from 0.75 for 2-week 
periods to 0.71 for periods over 3 years), and has been shown to have good construct 
validity in clinical and non-clinical populations [209]. Previous research around ASI and 
exercise training has reported clinically meaningful improvements defined as a reduction 
in total ASI of one or more standard deviations (9 points) from pre to post-exercise 
intervention [200].  
The BSQ was administered to determine participants’ fear of anxiety-related 
physiological sensations. Fear is described as a feeling of perceived danger or threat and 
research has shown that a fear of anxiety is highly associated with worry [210]. The BSQ 
is a 16-item questionnaire comprised of sensations related to autonomic nervous system 
arousal, scored on a 5-point likert scale (0=very little to 5=very much) used to determine 
the magnitude of which the sensations elicit nervousness or feelings of fright. The BSQ 
has been shown to have good test re-test reliability (r = 0.67) and high internal 
consistency (Cronbach alpha = 0.87) [211]. To date, there are no established minimally 
important clinical differences for this tool. In the study by Bromon et al (2004), described 
above, significant improvements in BSQ from pre to post-intervention were observed 
among those in the high intensity group (pre: 2.52 ± 0.53; post: 1.96 ± 0.53) but not in the 
low intensity group (pre: 2.69 ± 0.57; post: 2.5 ± 0.65) [200]. We thus expect that as a 
result of repeated exposure to bodily sensations during exercise, adults with asthma will 
experience reductions of approximately 0.5 in their BSQ score.   
The GAD-7 is a 7-item tool used to determine symptoms of generalized anxiety disorder. 
Adults with asthma have a greater prevalence of anxiety related disorders [144] and thus, 




it is possible that adults with asthma have undiagnosed GAD, due to their asthma. 
Participants are required to think back over the past 2-weeks and report how often they 
were bothered by 7 core generalized anxiety disorder symptoms (i.e. feeling nervous, 
anxious or on edge). Response options are “not at all”, “several days”, “more than half 
the days”, and “nearly every day”, scored as 0, 1, 2, and 3, respectively. Scores of  >5, 
>10, >15 represent mild, moderate, and severe level anxiety symptoms [212]. Clinically 
meaningful reductions in the GAD-7 are determined by a change in classification (i.e. 
reduction from severe (>15) to moderate anxiety (>10)). 
Asthma specific anxiety was assessed using a researcher developed visual analog scale 
(VAS). The VAS is a common tool used to overcome issues with Likert-type scales such 
as the ambiguous number of response categories [213]. The VAS overcomes this issue by 
providing respondents with a visual field rather than numerical and greatly reduces the 
risk of memory or expectation bias over time. As such, it has been argued that the VAS 
provides a more accurate representation of the respondents experience versus likert scales 
[214]. The VAS consisted of a 10cm straight line with the endpoints defining extreme 
limits. Participants were asked to mark on the line between the endpoints to determine 
each of the following “Please place an “x” along the line below at a point that you feel 
best represents 1) how much of a barrier is your asthma to exercise participation 2) how 
much anxiety do you experience due to your asthma when thinking about exercise 
participation, 3) how confident do you feel in your ability to exercise without 
experiencing asthma symptoms (without taking medication).” The distance between the 
mark and the endpoints determined the VAS scores for each scale. In previous studies 
using a VAS to determine anxiety pertaining to breathlessness during exercise, a change 




of 2cm was considered significant from pre to post-10 week intervention [197] . Due to 
the shorter intervention period and the younger and less anxious participants in the 
current study, we considered a 1.5cm change to be clinically meaningful.  
Statistical Analyses 
Means and standard deviations were used to describe the sample. Paired samples t-tests 
were conducted to determine differences from pre to post-intervention for all anxiety 
outcomes. Statistical significance was declared at p<0.01 (Bonferroni correction applied 
to adjust for multiple comparisons (n=5)). A repeated-measures ANOVA using mixed-
effects models was conducted to determine the interactions between men and women and 
ASI outcomes, BSQ, and the GAD-7. The independent variables in the 2 × 2 × 2 mixed-
effects ANOVA were gender, anxiety measure, and Time (pre-treatment and post-
treatment). Effect sizes were calculated by determining the standardized difference 
between the two means (mean pre-intervention)-(mean post-intervention)/standard 
deviation. Cohens d effect sizes were categorized as small (0.2), moderate (0.5), or large 
(0.8).  All statistics were completed in IBM SPSS statistics 25.0 (Armonk, NY) and 
statistical significance was declared at p<0.05. 
 RESULTS 
Participants (n=20) were 22.5 ± 3.2 years and 11 of 20 were female. Additional 
participant characteristics can be found in Table 1.  
 
 













Results from total ASI and each component are displayed in Figure 1. Total ASI 
improved from pre to post-intervention (PRE: 17.9 ± 11.8; POST 12.4 ± 13, p = 0.002, 
Cohens d = 0.4). A total of 3/20 (15%) of participants experienced a clinically 
meaningful improvement from pre to post intervention. At pre-intervention 7/20 
participants were classified as low anxiety sensitivity whereas, at post-intervention 16/20 
were classified as low anxiety sensitivity. No differences were observed in the ASI-SC 
(PRE: 8.6 ± 5.4; POST 6.4 ± 5.9, p = 0.04, Cohens d = 0.3), the ASI-PC (PRE: 5.2 ± 4.4; 
POST 3.2 ± 4.2, p = 0.051, Cohens d = 0.6) or the ASI-CC (PRE: 4.1 ± 4; POST: 2.8 ± 
4.4, p=0.08, Cohens d = 0.4) from pre to post-intervention. 
 
 
Characteristic   
Sex (M/F) 9/11 
Age (years) 22.5 ± 3.2 
Height (cm) 169.5 ± 7.2 
Weight (kg) 73.8 ± 12.8 
Forced Expiratory Volume in 1 
Second at Baseline 
3.3 ± 0.8 
Forced Expiratory Volume Post-
Intervention 
3.5 ± 0.8 
Peak Power Output at Baseline 217.8 ± 49 
Peak Power Output Post-
Intervention 
252.1 ± 56.8 * 




Figure 3.1. ASI Total & ASI Components Pre and Post-Intervention 
 
 
BSQ improved from pre to post intervention (PRE: 2.4 ± 1.0; POST: 2.0 ± 0.8, p=0.007, 
Cohens d = 0.3). No differences were observed for the GAD-7 (PRE: 14/20 low, 6/20 
high; POST: 15/20 low, 5/20 high).  
Improvements in the VAS “how much of a barrier is your asthma to exercise 
participation” (mean pre = 3.7 ± 2.7, mean post = 2.0 ± 1.2; p=0.002, Cohens d = 0.8) 
and VAS “how much anxiety you experience due to your asthma when thinking about 
exercise participation” were observed (mean pre = 2.8 ± 2.5, mean post = 1.3 ± 1.1; 
p=0.005, Cohens d = 0.5). No difference was observed in VAS “how confident you feel 
in your ability to exercise without experiencing asthma symptoms (without taking 
medication)” was observed (p=0.053, Cohens d = 0.4).  




Results from the mixed-effects ANOVA revealed no significant interactions between 
gender and any of the anxiety outcomes; however, a trend towards a significant 
difference was observed between men and women for the cognitive concerns component 
of the ASI (F(1,1) = 3.025, p=0.072). 
DISCUSSION 
The purpose of the present study was to determine whether a 6-week HIIT intervention 
would lead to improvements in general anxiety, anxiety sensitivity, and asthma related 
exercise anxiety among adults with asthma. Our primary finding is that a 6-week HIIT 
intervention leads to improvements in anxiety sensitivity and asthma specific exercise 
anxiety in adults with asthma with non-clinical anxiety. These results are in line with 
previous research examining the impact of aerobic exercise training on reducing anxiety 
among clinical and non-clinical populations [201], and indicate that HIIT may be a useful 
tool when working with adults with asthma.   
Our hypothesis that a 6-week HIIT intervention would lead to improvements in anxiety 
sensitivity was confirmed using a sample of 20 adults who had low levels of anxiety 
sensitivity and well-controlled asthma at baseline. The strength of the effect size 
observed in the ASI-PC subcomponent, suggest that a 6-week HIIT intervention may 
play an important role in reducing physical sensations that are commonly experienced 
during exercise as well as during an asthma exacerbation (i.e. shortness of breath). These 
findings are in line with previous research that has reported that exercise frequency and 
exercise intensity play an important role in reducing anxiety sensitivity [198, 199]. It is 
likely, that the frequency (i.e. 3 times per week) paired with the high intensity nature of 
the present protocol (i.e. 90% PPO for 1 minute, 10% PPO for 1 minute) offered repeated 




exposure to the potentially feared stimuli (i.e. asthma related symptoms during exercise) 
and thus led to the reductions in anxiety sensitivity among adults with asthma. Despite 
the low baseline levels of anxiety sensitivity, and the health of the sample, 15% of 
participants experienced clinically meaningful improvements. Previous research has 
shown clinically meaningful changes in over 50% of participants  [200]. The differences 
in the proportion of those experiencing these clinically meaningful improvements is 
likely explained by the differences in anxiety sensitivity scores at baseline between 
studies. Specifically, the present studied included individuals with asthma without a self-
reported diagnosis of a mental health condition; whereas, in the study by Bromon and 
colleagues participants had to have a minimum score of >25 on the ASI at pre-
intervention. The average ASI score at baseline in the present study was 17.9 ± 11.8 
compared to 34.17 ± 6.3 in the Bromon study [200]. Of note, despite the lower ASI 
scores in the present study at baseline, 9/20 (45%) of participants moved down into the 
low ASI classification from pre to post-intervention. These findings therefore have 
important implications for exercise prescription among adults with asthma, regardless of 
whether they have an existing diagnosis of anxiety.  
The inclusion criteria of adults with asthma without a diagnosis of a mental health 
condition may also explain why no differences were observed in GAD-7 from pre to 
post-intervention and why few clinically meaningful differences were reported. Future 
research should assess the impact of varying HIIT protocols (i.e. frequency and intensity) 
in order to better determine and prescribe the optimal exercise for reducing anxiety 
sensitivity among adults with asthma. As well, research should aim to assess the impact 
of chronic HIIT training among adults with asthma and with high anxiety sensitivity 




(>25) in order to better determine the impact of HIIT on anxiety sensitivity among adults 
with asthma.  
Our observation that the fear of experiencing anxiety related sensations improved 
following 6-weeks of HIIT is in line with previous research. Specifically, previous 
studies have reported improvements in the level of fear surrounding anxiety related 
sensations, using the BSQ, following 5 sessions of moderate intensity exercise [199]. In a 
study among adults with agoraphobia (n=77) participants were randomized into either a 
low intensity exercise or moderate intensity exercise group with a combination of 
cognitive behavior therapy. Results showed that greater improvements in BSQ were 
reported among those in the moderate intensity group [202] thus, suggesting that exercise 
intensity plays an important role in reducing anxiety. To date, no study has examined the 
impact of HIIT on reducing fear of anxiety related sensations among adults with asthma; 
however, it appears that among adults with asthma and without a diagnosis of a mental 
health condition, HIIT can lead to improvements in levels of fear of anxiety related 
sensations. Reducing fear of these sensations may lead to a reduction in barriers related to 
regular exercise among this population.  
Our hypothesis that a 6-week HIIT intervention would lead to improvements in asthma 
specific exercise anxiety was also confirmed. Participants in the present study reported a 
significant reduction in asthma-related barriers to exercise participation and reported 
significantly reduced anxiety at the thought of exercise using the VAS. These findings are 
in line with previous research that has implemented VAS to assess anxiety among adults 
with asthma,  which found significant improvements in feelings of fear surrounding 
breathlessness during exercise following a 10-week HIIT swimming intervention [197]. 




Reductions in asthma related barriers to exercise and improved perceptions of anxiety 
have important implications for exercise prescription among adults with asthma. Of note, 
an important limitation to consider in the present study is the lack of validity and 
reliability of the VAS used. Unfortunately, no validated or reliable VAS scales exist for 
assessing exercise-specific anxiety among adults with asthma. Importantly, the two VAS 
scales used in the present study that revealed significant improvements also yielded large 
and moderate effect sizes. The strength of these effect sizes suggest that a 6-week HIIT 
intervention may have important implications in improving asthma-specific anxiety 
surrounding exercise participation. Future research should aim to create valid and reliable 
tools to assess asthma specific anxiety among adults with asthma in order to better 
understand the impact of exercise training on these outcomes. 
The lack of gender differences observed in the present study add to the evidence that 
gender may not impact improvements in anxiety following exercise training [202]. A 
study implementing a 2-week moderate to high intensity (60-80% heart rate) exercise 
intervention reported that men experienced greater reductions in anxiety in response to 
exercise training compared to women, these reported differences were only evident mid-
treatment [202]. Similar findings were reported in the study described above by Bromon 
and colleagues (2004), in that following the first week of exercise training, men had a 
greater reduction in anxiety when compared to women; however, following the 2-weeks 
of exercise training men and women had similar improvements [200]. Therefore, one 
important limitation of the present study is the lack of mid-treatment anxiety assessment. 
It is possible that there may be gender differences in the rate at which anxiety improves in 
response to exercise. Interestingly, the present study reported a trend towards significance 




in the cognitive component of the ASI wherein, men had higher anxiety scores within this 
sub-component. This is in line with previous research that has reported men typically 
score higher than women on this sub-component while females typically score higher on 
the PC component [201]; however, the present study did not find a higher score for 
women on the PC component. Thus, it is possible that at non-clinical levels of anxiety, 
gender differences do not occur. Of note, it is possible that the present study was 
underpowered and thus, definitive gender differences in anxiety cannot be determined.  
In conclusion, it appears that a 6-week HIIT intervention is able to reduce anxiety 
sensitivity and asthma-specific anxiety among adults with asthma who have non-clinical 
levels of anxiety. Furthermore, it appears that reductions in anxiety sensitivity and asthma 
specific anxiety occur following a 6-week HIIT intervention, regardless of gender. Future 
large scale randomized control studies should aim to evaluate the differences in different 
intensities of exercise training and their impact on reducing anxiety sensitivity and 
asthma specific exercise anxiety among adults with asthma.  
  




Connecting Statement III 
In the previous three chapters, we’ve reported a reduction in inflammation, an 
improvement in aerobic fitness, a lack of improvement in indices of ventilation among 
adults with EIBC, and a reduction in anxiety levels. As stated previously, improvements 
in aerobic fitness have been linked to improvements in asthma control[10]. As well, the 
reduction in anxiety observed following HIIT may have led to a de-sensitization to 
asthma related symptoms (i.e. dyspnea) as a result of repeated exposure and thus, may 
have reduced perceptions of the frequency and severity of asthma symptoms; therefore, 
leading to an improvement in asthma control. As such, the following chapter will 
examine the impact of a 6-week HIIT intervention on clinical outcomes of asthma.  
  




Chapter 6: Low volume high intensity interval training leads to improved asthma control 
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Regularly engaging in aerobic exercise is associated with improved asthma control and 
quality of life. Previous research has focused on continuous aerobic exercise; the impact 
of high intensity interval training (HIIT) on asthma control is poorly described. 
METHODS: A six-week, low volume HIIT intervention (3 times/week, 20 minute bouts) 
was conducted in adults with asthma (n=20). Asthma control was assessed using the 
Asthma Control Questionnaire (ACQ). RESULTS: ACQ improved from pre to post 
intervention (pre: 0.8 ± 0.6; post: 0.5 ± 0.4, p = 0.02, Cohens d = 0.5). In total, 7/20 
(35%) participants experienced clinically meaningful improvements in ACQ. 
CONCLUSION: A low-volume HIIT intervention leads to statistically and clinically 
significant improvements in asthma control as well as improved exertional dyspnea and 
exercise enjoyment.  




Exercise acts a trigger for bronchoconstriction in approximately 90% of adults with 
asthma [3].  Exertional dyspnea, that is,  shortness of breath during exercise [216], is 
commonly experienced among those with asthma and may be a barrier to regular 
exercise. Nevertheless, asthma control and exertional dyspnea can be improved by 
engaging in regular exercise training, particularly aerobic exercise [10, 217, 218].   
Adherence to aerobic exercise among adults with asthma is suboptimal [164]. 
Interestingly, while research suggests that adults with asthma are less likely to engage in 
higher intensity activities [219], recent work from our laboratory showed that adults with 
asthma enjoy high intensity interval exercise more than moderate intensity continuous 
exercise (MICE) [220]. This may be particularly relevant in adults with asthma, as 
continuous exercise requires sustained ventilations, which results in evaporative water 
and heat loss from the airways [4] thus, triggering bronchoconstriction. In fact, work 
from our laboratory also found that an acute bout of high intensity interval exercise led to 
a smaller decline in FEV1 post-exercise than MICE [162]. The high intensity interval 
exercise was also associated with lower exertional dyspnea during exercise, and greater 
exercise enjoyment.  
High intensity interval training (HIIT) is composed of brief bouts of high intensity 
activity followed by intermittent recovery periods. Based on our work, HIIT appears to 
be a safe option for exercise prescription; however, limited research exists on the impact 
of regularly engaging in HIIT on asthma control, exertional dyspnea, and exercise 
enjoyment. The purpose of this study was to determine the impact of a 6-week, low 
volume HIIT intervention on asthma control among adults with asthma. We also wanted 
to determine the impact of HIIT on exertional dyspnea during exercise and exercise 




enjoyment following the 6-week HIIT intervention. We hypothesized that despite the low 
volume, regular participation in HIIT would lead to improvements in asthma control and 
exertional dyspnea based on previous research indicating such responses to MICE [10], 
and that exercise enjoyment would improve due to desensitization to exertional dyspnea 
symptoms [218, 221], and improvements in asthma control.  
METHODS 
Study Protocol 
A one group pre-test (first HIIT session), post-test (last HIIT session) study design was 
conducted in which eligible participants (non-smoking, moderately active adults with a 
self-reported physician diagnosis asthma, with a current prescription for a short-acting 
bronchodilator, aged 18-44 years) completed 6 weeks of HIIT, 3 times per week on a 
cycle ergometer (5 minute warm-up at 25 Watts, followed by 10% peak power output for 
1 minute, 90% peak power output for 1 minute, repeated 10 times).  
Spirometry 
Participants performed three repeatable lung function maneuvers using a handheld 
spirometer  (EasyOne, Medizintechnik AG, Zurich, Switzerland) in accordance with the 
American Thoracic Society Guidelines before exercise at pre and post HIIT sessions 
[222]. At minutes 5, 10, 15, and 20 post-exercise during the pre and post HIIT sessions, 
FEV1 was re-assessed in duplicate. The highest FEV1 value at each of the post-exercise 
time points was used to determine FEV1 decline. The decline in FEV1 was calculated as 
follows: 
% Fall in FEV1 = 100 [FEV1 pre-challenge – FEV1 post-challenge] / FEV1 pre-challenge. 




The maximum FEV1 decline following exercise were used for statistical analysis. 
Participants were not permitted to take their short-acting bronchodilator prior to any of 
the HIIT sessions; however, participants were permitted to maintain their regular usage of 
inhaled glucocorticoids throughout the duration of the intervention. 
Asthma Control  
 
Asthma control was assessed using the Asthma Control Questionnaire (ACQ) -7 at pre 
and post HIIT sessions. The ACQ has been shown to have strong evaluative and 
discriminative properties and can be used to measure asthma control with confidence 
[193]. A score on the ACQ of <0.75-1.5 is indicative of relatively well-controlled asthma 
and a score >1.5 indicates poorly controlled asthma. A change on the ACQ >0.5 is 
considered clinically significant.  
Exercise Enjoyment 
Exercise enjoyment was assessed 5-minutes following pre and post HIIT sessions using 
the Physical Activity Enjoyment Scale. Given that the questionnaire was used post-
exercise, the questionnaire was modified by removing the following question “I am very 
absorbed in this activity-I am not very absorbed in this activity.” Each question is scored 
on a 7-point bipolar scale with a maximum score of 119. This modified version has been 
used previously for the assessment of HIIT [162, 223]. 
Exertional Dyspnea 
Exertional dyspnea was assessed each minute during the second and 17th session using 
the Ratings of Perceived Dyspnea (RPD) scale. RPD was not measured during the first 




and last session due to timing of various measurements. The peak RPD and the average 
RPD for each minute during exercise was used for analysis. The RPD scale has been 
shown to be valid and reliable for use during exercise [224].  
 
Statistical Analysis 
Means and standards deviations were used to describe the sample. Paired samples t-tests 
were used to determine differences between pre and post HIIT sessions.  A repeated 
measures ANOVA was used to determine differences in FEV1 (L/min) from before and 
after the exercise session at pre and post HIIT sessions. A repeated measures ANOVA 
was used to determine differences in RPD at pre and post HIIT sessions. Effect sizes 
were calculated by determining the standardized difference between the two means 
(mean pre-intervention)-(mean post-intervention)/standard deviation. Cohens d effect 
sizes were categorized as small (0.2), moderate (0.5), or large (0.8). As well, estimated 
effect sizes were reported using partial eta squared (hp
2) values from the ANOVA. Partial 
eta squared effect sizes were categorized as small (hp
2 = 0.01), medium (hp
2 = 0.06), and 
large (hp
2 = 0.14) All statistics were completed in IBM SPSS statistics 26.0 (Armonk, 
NY) and statistical significance was declared at p<0.05.  
All participants provided written informed consent prior to participation in the study. 
This study was approved by the Research Ethics Board at the University of Ontario 
Institute of Technology.  
 
 





Participants (n=20) were 22.5 ± 3.2 years and 11 of 20 were female. Nine participants 
had good asthma control (ACQ>0.5) and three had poor asthma control (ACQ >1.5) at 
baseline. FEV1 did not change from pre to post-exercise (F(1,19) = 0.3, p=0.5, hp
2 = 
0.01).  
Improvements in ACQ were observed when comparing pre and post HIIT sessions (pre: 
0.8 ± 0.6; post: 0.5 ± 0.4, p = 0.02, Cohens d = 0.5). A total of 7/20 (35%) participants 
experienced clinically meaningful improvements in ACQ. Those who experienced a 
clinically meaningful improvement in asthma control had the highest ACQ at pre-
intervention (1.5 ± 0.5, n=7); no differences were observed between these groups (high 
vs. low ACQ at pre-intervention) in baseline characteristics. Figure 1 illustrates the 









































During the first HIIT session, four participants were unable to complete the session due to 
volitional fatigue. Thus, only participants who completed the full 20 minute session were 
included for RPE analysis (n=16). No differences were observed in peak RPD; however, 
significant improvements were observed in average RPD when comparing pre and post HIIT 
sessions (pre: 4.3 ± 1.8; post: 3.1, p = 0.03, Cohens d = 0.8). Figure 2 illustrates the changes 
observed in average exertional dyspnea during each minute of exercise during the pre and post-
HIIT sessions. 





Figure 4.2. Perceived dyspnea during exercise at pre-intervention and post-intervention (n=16) 




Improvements in exercise enjoyment were observed when comparing pre and post HIIT sessions 
(pre: 69.5 ± 7.3; post: 73.25 ± 6.3, p=0.03, Cohens d = 0.8).  
DISCUSSION 
The purpose of this study was to determine the impact of a HIIT intervention on asthma control, 
exertional dyspnea, and exercise enjoyment. Our primary finding is that a 6-week, low volume 
HIIT intervention led to statistically and clinically significant changes in asthma control. We also 
found that exertional dyspnea was reduced and exercise enjoyment was improved following the 
intervention. Together, these findings suggest that HIIT can be prescribed to adults with asthma, 
and may even be a preferred exercise option. 
As hypothesized, HIIT led to improvements in asthma control. This is in line with previous 
research on changes in asthma control following exercise training. Specifically, following a 12-
week moderate intensity exercise training program among adults with asthma (n=18), ACQ 
scores improved from 1.3 (±0.19) to 0.72 (±0.17), while a study of overweight adults with 
asthma (n=55) found that 69% of participants experienced improvements in asthma control over 
12 weeks of moderate intensity exercise training [225]. In our study, ACQ improved from 0.8 ± 
0.6 to 0.5 ± 0.4, and 35% of the sample has clinically meaningful improvements. This is 
important as the majority of previous research has examined the impact of larger volume 
interventions, that is, exercise sessions are typically longer (e.g. >30 minutes) and the length of 
the intervention is greater (>12 weeks) [10, 225, 226]. The improvements observed in our study 
occurred following only 6-weeks of exercise training that consisted of one hour per week of 
exercise. Thus, adults with asthma who wish to improve asthma control but indicate that time is a 
barrier to adopting exercise, could be advised to perform HIIT instead of MICE.   




We also hypothesized that RPD during exercise would be reduced due to desensitization to 
exertional dyspnea symptoms due to repeated exposure to HIIT. It should be noted that improved 
cardiorespiratory fitness is likely the primary reason for the observed improvements in RPD; 
however, repeated exposure to a feared stimuli (i.e. dyspnea among adults with asthma) may 
result in a desensitization to that stimuli [204, 221] and thus, may explain the improvements 
observed in exertional dyspnea during exercise. Our data suggest that average RPD did improve; 
this is in line with previous literature reporting an improvement in exertional dyspnea (using the 
Medical Research Council dyspnea scale) from 2.58 (±0.69) to 1.37 (±1) over an 8 week 
moderate continuous exercise intervention [227].  In other words, HIIT would allow adults with 
asthma to perform daily activities that require higher intensities at a lower level of perceived 
dyspnea. This is important for asthma related quality of life and overall perceptions of asthma 
control [228].    
Finally, our hypothesis that the intervention would improve exercise enjoyment was also 
confirmed [227]. These improvements may have important implications for increasing exercise 
adherence among this population, given the strong association between exercise enjoyment and 
future exercise participation [229]. Improving exercise adherence would have an important 
impact on health, asthma control, and asthma related symptoms among adults with asthma.  
The results of the present study should be interpreted in light of the following limitations. First, 
the majority of participants in the present study had good asthma control and thus, the 
generalizability of these findings among adults with less controlled asthma is limited. As well, 
our sample was composed of younger adults and thus, caution should be aired when generalizing 
these findings to older adults with asthma. Despite these limitations, these findings offer promise 




for the implementation of HIIT among young adults to help improve asthma control and asthma 
symptoms.  
In conclusion it appears that a 6-week, low volume HIIT intervention is able to improve asthma 
control, exertional dyspnea, and exercise enjoyment among adults with asthma. These findings 
suggest that clinicians and allied healthcare professionals working with adults with asthma can 
counsel patients on incorporating HIIT. Further work is needed to better understand differences 
in adherence to HIIT versus MICE programs in adults with asthma.  
  




CHAPTER 7: EXTENDED METHODS  




Study Design: A 6-week high intensity interval training (HIIT) intervention among adults with 
and without exercise induced bronchoconstriction (EIBC) was conducted, using a quasi-
experimental study design. Exercise training occurred 3 times per week for 6 weeks. All exercise 
training was conducted on a cycle ergometer, and all exercise sessions were supervised by 
researcher or a trained research assistant.  
Participants:  
Inclusion Criteria EIBC Group: Inclusion in the EIBC group was limited to adults between the 
ages of 18-44 years, with a current prescription for a short-acting bronchodilator, who were 
participating in ≤ 150 minutes of moderate to vigorous intensity physical activity per week, who 
were not taking medications that could alter the outcomes of interest (with the exception of 
asthma medications), and who were non-smokers. Further eligibility criteria included a positive 
response to either the eucapnic voluntary hyperpnea (EVH) challenge or the bronchodilator 
reversibility assessment to confirm EIBC (described below).  
Inclusion Criteria Control Group: Inclusion in the control group was limited to adults between 
the ages of 18-44 years, who were participating in ≤ 150 minutes of moderate to vigorous 
intensity physical activity per week, who were not taking medications that could alter the 
response of the outcomes of interest, and who were non-smokers.  
Exclusion Criteria: The upper age limit of 44 years was to minimize inclusion of participants 
who may have had undiagnosed chronic obstructive pulmonary disorder (COPD), or 
compromised lung function.[230] Participants who were current smokers were excluded from 
this study, due to the likelihood that smokers would present with more impaired lung function 
and an increase in inflammation.[231] Participants with musculoskeletal injuries that would 




impact performance or exacerbate their injury on the cycle ergometer were excluded from this 
study. Certain types of medications, for example beta blockers, alter cardiovascular 
responses;[232] therefore, participants using those medications were excluded from this study. 
Participants with a diagnosis of a mental health problem (i.e. depression, generalized anxiety 
disorder) were excluded from this study, in order to obtain a more homogenous and accurate 
representation of the impact of a HIIT intervention among adults with non-clinical mental health 
issues. Pregnant women were excluded from the study.  
Recruitment: Participants were primarily recruited from the UOIT North and Downtown 
campuses using posters displayed on the campuses, announcements made in undergraduate 
lectures and laboratories, posts made on Dr. Dogras’ laboratory website, and through word of 
mouth. Permission was sought from course instructors to make classroom announcements in 
undergraduate courses. Recruitment was also conducted at local community and fitness centers 
in Whitby and Oshawa, with the use of recruitment posters. Efforts were made to ensure 
participants in each group were age and sex matched.  
Sample Size: GPOWER statistical software indicated that for a medium effect size (0.5) with an 
alpha of 0.05 and a power of 0.95, 16 participants for each group were required for this study.  
  




Overview of Sessions 
Pre-Screening and Familiarization, Pre-Intervention, and Post-Intervention Testing Sessions: 
Individuals that met the inclusion criteria (described above) were asked to provide written 
informed consent prior to participation. Eligible participants were asked to attend a pre-screening 
and familiarization session, used to confirm EIBC. Participants were also asked to attend a pre-
intervention session to determine peak power output (PPO) prior to the HIIT intervention. 
Details on each of these sessions are described below. Following the 6-week HIIT intervention, 
participants attended a post-intervention session to determine training improvements in the 
outcomes described below. Prior to each of these sessions, participants were emailed the 
following instructions: 
o refrain from taking any long acting medication 48 hours prior to testing 
o refrain from taking short acting medication 8 hours prior to testing 
o refrain from consuming caffeinated beverages at least 4 hours prior to testing 
o refrain from consuming a heavy meal at least 2 hours prior to testing 
o bring shorts and sneakers to testing session 
o bring current rescue medication to testing session  
Additionally, in order to accurately assess salivary markers of inflammation participants were 
asked to document the following prior to pre-intervention and post-intervention testing sessions:  
o consumption of alcohol, caffeine, nicotine, and prescription/over-the-counter medications 
within the 12 hours prior to sample collection 
o consumption of meals within the previous 60 minutes 
o consumption of foods with high sugar, acidity, or caffeine content, immediately before 
sample collection 




o physical activity levels 24 hours prior to sample collection 
o the presence of any oral disease or injury 
Exercise Sessions 1 & 18: Following the pre-screening and familiarization and the pre-
intervention testing sessions, participants were asked to complete a total of 18 exercise sessions 
(3 sessions per week for 6 weeks). During exercise sessions 1 and 18 inflammatory, pulmonary, 
cardiovascular, and psychological variables were assessed. Details on each of these parameters 
and assessment methods are described below. Prior to exercise sessions 1 and 18 participants 
were emailed the following instructions: 
o refrain from heavy exercise at least 24 hours prior 
o refrain from consuming a heavy meal at least 2 hours prior  
o refrain from consuming caffeinated beverages at least 4 hours prior  
o refrain from taking any short acting asthma medication at least 8 hours prior 
o bring shorts and sneakers to the testing session 
o bring current rescue medication to testing session 
Additionally, in order to accurately assess salivary inflammation participants were asked to 
document the following prior to exercise sessions 1 and 18:  
o consumption of alcohol, caffeine, nicotine, and prescription/over-the-counter medications 
within the 12 hours prior to sample collection 
o consumption of meals within the previous 60 minutes 
o consumption of foods with high sugar, acidity, or caffeine content, immediately before 
sample collection 
o physical activity levels 24 hours prior to sample collection 




o the presence of any oral disease or injury 
Exercise Sessions 2 & 17: During exercise sessions 2 and 17 participants completed the exercise 
protocol. Perceptions of effort and dyspnea and in-task affect were assessed each minute during 
exercise. Physical activity enjoyment was assessed following the exercise protocol. Participants 
were emailed the following instructions prior to exercise sessions 2 and 17: 
o Refrain from consuming caffeinated beverages at least 4 hours prior to testing 
o Refrain from consuming a heavy meal at least 2 hours prior to testing 
o Withhold any short acting asthma medication 8 hours prior to testing 
o Bring your current rescue medication to the testing session  
Exercise Sessions 3-16: During sessions 3-16 participants completed the HIIT sessions under the 
supervision of the researcher or a trained research assistant. Research assistants were instructed 
to limit interaction with the participants, in order to help prevent influencing enjoyment variables 
(described below) during the session. In order to ensure participant safety, for each HIIT session 
participants were instructed to bring their short acting bronchodilator. HIIT sessions were 
cancelled if the participant forgot their medication. 
  




Variables of Interest 
Inflammation 
Salivary Cytokines: 
Measurement: Concentrations of salivary cytokines were assessed (Salimetrics, USA). Upon 
arrival to the laboratory, participants were provided with water to rinse their mouths, in order to 
remove any food residue. The sample was collected a minimum of 10 minutes following rinsing. 
Participants were instructed to pool saliva in their mouth and provide a sample in a high quality 
polypropylene 2mL cryovial (Salimetrics Item No. 5002.01, USA). In order to assist participants 
in obtaining the required sample volume, participants were prompted to think of eating salty foods 
(i.e. pickles, potato chips). Samples were immediately placed on ice, securely sealed and packaged 
prior to transport to a Level 2 Biohazard laboratory. Samples were transported in accordance with 
the Transportation of Dangerous Goods Act and regulations. Samples were then aliquoted into 
0.5ml vials, samples were sealed tightly and coded, using labels recommended for freezing (i.e. 
cryolabels), and placed in a -80 degree freezer until analysis. For additional information on saliva 
sample procedures refer to Appendix C2.   Enzyme immunoassay kits for pro-inflammatory 
cytokines Tumor necrosis factor (TNF) a, interleukin (IL)-1β, IL-8, and Interferon-gamma 
inducible protein, CXCL10/ (IP-10) CXCL10/IP-10 and anti-inflammatory cytokines interleukin-
1 Receptor antagonist (IL-1Ra) and transforming growth factor beta (TGF-β) were used to analyze 
saliva samples. Saliva samples were thawed and centrifuged for 15 minutes at 1500 x g to pellet 
mucins and other debris. Prior to cytokine analysis, total protein content within each saliva sample 
was determined using the Coomassie PLUS Protein Assay Reagent (Thermo Fisher Scientific, 
MA, USA). Levels of IL-8 (R&D Systems, Catalog# DY208), IL-1Ra (R&D Systems, 
Catalog#DY280), and TNF α (R&D Systems, Catalog# DY210) were determined in both EIBC 




and non-EIBC groups using enzyme-linked immunosorbent assays (ELISA) following 
manufacturer’s protocols (R&D Systems, MN, USA). Levels of IL-1β (R&D Systems, Catalog# 
DY201) and CXCL10/IP-10 (R&D Systems, Catalog#DY266) were determined in the EIBC group 
only, using enzyme-linked immunosorbent assays (ELISA) following manufacturer’s protocols 
(R&D Systems, MN, USA). Samples were analyzed using 96-well high-binding microplates 
(Greiner Bio-One, Frickenausen, Germany) and plates were read at a wavelength of 450 nm using 
a Synergy HTTR microplate reader (Bio-Tek Instrumentation, VT, USA). Cytokine data was 
standardized with the amount of total protein found within each saliva sample and expressed as 
pg/µg of protein.  
Time of Measurement: Concentrations of salivary levels of cytokines were assessed before and 
15-30 minutes after exercise during the pre-intervention and post-intervention testing sessions. 
As well, saliva samples were collected before and 15-30 minutes after exercise during exercise 
sessions 1 and 18. Among the EIBC group, samples were collected in duplicate during the pre-
intervention testing session and exercise session 1.  
 
Pulmonary 
Maximal Oxygen Consumption (VO2max) and Ventilation  
Measurement: A metabolic cart (Parvo Medics, TrueOne 2400, Murray, Utah USA) was used 
during maximal exercise testing on the cycle ergometer (Lode Excalibur, Gronigen, The 
Netherlands). Expired CO2 and O2 was collected through a pneumotachograph and analyzed 
using an automated gas collection system. Participants’ with EIBC were instructed to take their 
medication 15 minutes prior to maximal exercise testing to ensure safety and to determine 




bronchodilator reversibility (described below). The cycle ergometer was adjusted to the 
appropriate height for each participant by adjusting the seat to hip level. Participants were fitted 
with the headset and mouthpiece required for direct gas analysis. Participants were then 
instructed to mount the cycle ergometer. A nose clip was placed on the participants’ nose to 
ensure all expired air is expelled via the mouth. Participants were instructed to maintain a closed 
seal around the mouthpiece at all times. Participants were then instructed to begin cycling at 70-
80rpm at 25Watts for a 5 minute warm-up. Exercise testing began at 25Watts, and increased by 
1Watt every 2 seconds until volitional exhaustion. Upon exhaustion, participants entered an 
active cool down and the mouthpiece was removed by the researcher 30 seconds post-
exhaustion. Outliers were visually determined and removed. VO2max was determined by taking 
a 5-breath average of the highest VO2 throughout the test. Ventilatory threshold was visually 
determined at the point where ventilation increased non-linearly to the increase in oxygen 
uptake, and by identifying the point at which carbon dioxide production increased at a faster rate 
than VO2.  
Time of Measurement: VO2max was assessed during pre-intervention and post-intervention 
testing sessions. Ventilatory variables were assessed during pre and post-intervention testing 
sessions and during exercise sessions 1 and 18.  
Cardiovascular 
Tissue Saturation Index (TSI) 
Measurement: A two-wavelength (765 and 855nm) continuous wave near infrared spectroscopy 
system (NIRS) was used to monitor TSI (Artinis Medical Systems, The Netherlands). The 
background and additional details of NIRS are described elsewhere.[189] Briefly, light in the 




near infrared range is used to determine relative concentrations of oxygenated and deoxygenated 
hemoglobin, due to their different absorption patterns. TSI represents a ratio of oxygenated 
hemoglobin to total hemoglobin, which indicates oxygen saturation in the tissue. For additional 
information on NIRS procedures as it pertains to the proposed study, refer to Appendix C3.  
Upon arrival to the lab, a thigh skin fold was taken at the midway point of the iliac crest and 
patella. Participants were then seated and fitted with a non-invasive probe that was attached to 
the belly of the quadriceps vastus lateralis muscle, 12 cm from the knee joint, along the vertical 
axis of the thigh. The probe was secured in place with an elastic strap, which was tightened to 
prevent movement, and covered with an optically dense, black vinyl sheet to minimize the 
intrusion of extraneous light and probe movement. A tensor bandage was applied over the black 
vinyl sheet to minimize movement of the probe. TSI during exercise was normalized and 
expressed as a percentage of TSI at rest.  
Time of Measurement: TSI was assessed during pre-intervention and post-intervention testing 
sessions and during exercise sessions 1 and 18.   
Heart Rate and Blood Pressure 
Measurement: Resting and exercise heart rates were monitored using a heart rate monitor (Polar 
V800). Resting blood pressure was assessed using a blood pressure cuff (Welch Allen, 
Germany). Upon arrival to the laboratory, participants were instructed to sit quietly in the 
laboratory for 5 minutes. Blood pressure was then manually assessed and recorded twice at the 
antecubital space using a stethoscope and sphygmomanometer (Welch Allen, Germany). 
Participants were then instructed to lift their shirt slightly above the Xiphoid process and were fit 
with a heart rate monitor (Polar, V800). The heart rate monitor was attached around the chest 
with a wearable strap, and a heart rate monitor watch was attached to the participants left wrist.  




Time of Measurement: Resting heart rate and resting blood pressure was assessed at the 
beginning of the pre-screening and familiarization, pre-intervention, and post-intervention testing 
sessions. As well, resting heart rate and blood pressure was assessed at the beginning of exercise 
sessions 1 and 18. Resting heart rate and blood pressure assessments taken during the pre-
screening and familiarization, pre-intervention testing, and post-intervention testing were used 
for safety purposes, while measurements taken at the beginning of exercise sessions 1 and 18 
were used for analysis. Exercise heart rate was assessed each minute of exercise during pre-
intervention and post-intervention testing and during exercise sessions 1 and 18.  
 
Psychological  
Anxiety & Anxiety Sensitivity 
Measurement: Anxiety levels were assessed using the Generalized Anxiety Questionnaire, the 
Anxiety Sensitivity Scale III, and Visual analog scales. The Anxiety Sensitivity Scale III has 
been shown to have higher construct validity and reliability than earlier versions [233]. 
Additional assessments of anxiety levels and exercise participation, specific to adults with EIBC, 
were assessed using 3 researcher developed Visual Analog scales evaluated on a 100mm scale 
(Appendix C1). Participants were provided with the Anxiety Sensitivity Scale III and the Visual 
Analog scales upon arrival to the laboratory during the pre-intervention and post-intervention 
testing sessions. Instructions for each scale was read by the researcher to the participant. 
Participants were then instructed to complete the scales. The following instructions were given to 
the participant in regards to the visual analog scales:  




o “A visual analog scale is a tool that aims to measure a characteristic or attitude that is 
believed to range across a continuum, for example anxiety. These visual analog scales 
will be used to measure your anxiety levels as it pertains to exercise participation and 
asthma. Please indicate on the scale your level of anxiety as it pertains to each question 
by marking an “x” on the scale.”  
Time of Measurement: Anxiety scales were completed during pre-intervention and post-
intervention testing sessions.  
 
Perceptual Feedback 
Perceived Dyspnea, Effort, and Exercise Enjoyment 
Measurement: Perceptions of effort were assessed in relation to leg fatigue using the Borg 
Ratings of Perceived Exertion Scale (6-20). The Ratings of Perceived Exertion Scale has been 
shown to be a reliable measure of exercise intensity (r = 0.83).[234] Perceptions of dyspnea were 
assessed using the modified Ratings of Perceived Dyspnea Scale (1-10). Affect was assessed 
using the 1-Item Feelings Scale. Exercise enjoyment was assessed using the Physical Activity 
Enjoyment Scale. The Physical Activity Enjoyment Scale has been shown to have a very high 
internal consistency (Cronbach’s alpha = 0.906) and good test-retest reliability (rho = 0.868, 
p<0.001).[235] Participants were familiarized with each scale, and were instructed to point to the 
number on the scale corresponding with how they feel at the end of each minute of exercise in 
relation to leg fatigue, breathlessness, and affect.  
Time of Measurement: Ratings of perceived exertion, ratings of perceived dyspnea, and the 1-
item feelings scale were assessed at the end of each minute of exercise during the pre-




intervention and post-intervention testing sessions, and during exercise sessions 2 and 17. The 
physical activity enjoyment scale was completed following exercise during exercise sessions 2 
and 17. 
 
EIBC Specific  
EIBC Confirmation 
Measurement: Participants had their height and weight assessed (described below) and the 
handheld spirometer was updated accordingly. Participants completed 3 repeatable lung function 
assessments using handheld spirometry (described below) to determine their forced expiratory 
volume in 1 second (FEV1) in accordance with the American Thoracic Society guidelines.[236] 
EIBC was confirmed using the EVH challenge. Participants were instructed to sit in front of the 
metabolic cart and were fitted with the mouthpiece, which was connected to the dry air used for 
the EVH challenge. Participants were fitted with a nose clip and were provided with a 30-second 
practice ventilation period, in order for participants to become familiarized with the required 
ventilation rate. Participants were given a 1 minute rest period breathing room air prior to the 
challenge. Participants were instructed to maintain a ventilation rate of 25-30 times their FEV1 at 
baseline (determined by the researcher) for 6 minutes. Spirometry was performed post EVH at 
minutes 5, 10, 15, and 20 to determine the decline in FEV1. If the participants FEV1 was not 
beginning to recover at 20 minutes post-EVH, participants were instructed to take their short 
acting bronchodilator. The percentage decline in FEV1 was calculated as follows:  
o 100 x (FEV1 (before test) – lowest value for FEV1 (20 minutes after the test)) / FEV1 
(before test). 




A decline in FEV1 from pre to post-EVH challenge of 12% or greater was considered a positive 
EIBC response. For additional details on the EVH protocol in the proposed study refer to 
Appendix C1.  
EIBC was also confirmed using a bronchodilator reversibility assessment. Upon arrival to the 
pre-intervention testing session, baseline spirometry was assessed. Participants were instructed to 
take their short acting bronchodilator. Fifteen minutes following bronchodilator administration, 
spirometry was re-assessed to determine improvements in lung function. A positive reversibility 
assessment was defined as > 12% increase and > 200mL as an absolute value compared to 
baseline FEV1 or forced vital capacity. 
Time of Measurement: The EVH challenge was conducted during the pre-screening and 
familiarization session and the bronchodilator reversibility was assessed during the pre-
intervention testing session.  
 
Lung Function 
Measurement: Lung function was assessed using a handheld spirometer (EasyOne, 
Medizintechnik AG, Zurich, Switzerland). Spirometry was conducted in accordance with the 
American Thoracic Society standardized protocols.[236] Participants were emailed a video on 
proper spirometry technique prior to the pre-screening and familiarization session. Upon arrival 
to the laboratory, participants were given the following verbal instructions:  
o “Please take a maximal inhale and at the top of the inhale, place your mouth over the 
mouthpiece and forcefully exhale as fast as you can and continue exhaling for 6 seconds, 
then take a maximal inhale.”  




Following the verbal instructions, participants were given a demonstration by the researcher or 
research assistant on proper spirometry technique. Participants were then fitted with a nose clip 
and were asked to perform spirometry according to standardized guidelines.  
Time of Measurement: During the pre-screening and familiarization session, spirometry was 
conducted pre-EVH challenge and at minutes 5, 10, 15 and 20 minutes post-EVH. During the 
pre-intervention and post-intervention testing sessions, spirometry was taken upon arrival to the 
laboratory, 15 minutes following medication administration, and 10 minutes post-maximal 
exercise test. Spirometry was conducted upon arrival to the laboratory and following exercise at 
5, 10, 15, and 20 minutes post exercise sessions 1 and 18. 
 
Asthma Control and Quality of Life 
Measurement: Asthma control was assessed using the Asthma Control Questionnaire. The 
Asthma Control Questionnaire was developed and validated to measure asthma control in 
adults.[193] Asthma related quality of life was assessed using the Mini-Asthma Quality of Life 
Questionnaire. The Mini-Asthma Quality of Life Questionnaire has been shown to have good 
reliability (Intra-class correlation coefficient=0.83) as well as validity, measured by 
responsiveness (p=0.0007).[237] Participants were read the instructions from the Asthma Control 
Questionnaire and the Mini-Asthma Quality of Life Questionnaire and were provided with a pen 
to complete the questionnaires.  
Time of Measurement:  Asthma specific outcomes were assessed at the beginning of exercise 
sessions 1 and 18.  
 





Height, Weight, and Waist Circumference 
Measurement: Height and weight were assessed using a standardized medical scale (Detecto, 
USA). Participants were instructed to remove their shoes, jacket, sweater, hat, and all extraneous 
materials from their pockets. Participants were then asked to step onto the scale and weight was  
measured to the nearest 0.1 kg and height was measured to the nearest 0.1 cm. Waist 
circumference was assessed using a measuring tape. Measurements were taken at the top of the 
border of the iliac crest on the right hand side of the body using the cross handed technique. 
Time of Measurement: Height was assessed during the pre-screening and familiarization session. 
Weight was assessed during the pre-screening and familiarization session, pre-intervention and 
post-intervention testing sessions, and during exercise sessions 1 and 18. Waist circumference 
was assessed during exercise sessions 1 and 18.  
 
Thigh Skinfold 
Measurement: Skinfold thickness of the thigh was measured midway between the proximal 
border of the patella and the inguinal crease, on the anterior midline of the thigh using calipers 
(Harpenden Skinfold Calipers, Baty International, United Kingdom). Participants were instructed 
to put their right foot forward balancing on their toe with all their weight on their back left leg. 
The anatomical location described above was landmarked using a common eyebrow pencil. The 
skin was grasped firmly with the thumb and index finger and the calipers were held 
perpendicular to the landmarked site. Calipers were placed one-quarter inch below the thumb and 
forefinger. The measurement was taken approximately 1 to 2 seconds after the trigger had been 




released and recorded to the nearest 0.5 millimeter. A minimum of two measurements were 
taken, with at least 15 seconds between measurements to allow the fat to return to normal 
thickness.  
 
Time of Measurement: Thigh skinfolds were assessed during pre-intervention and post-
intervention testing sessions and during exercise sessions 1 and 18. 
 




Session Overviews:  
 
















































































































Chapter 8: General Discussion 
 
Primary Overarching Goal 
The primary overarching goal of this dissertation was to examine the impact of HIIT on the 
physical,psychological, and clinical domains of health among adults with EIBC and healthy 
adults. In contrast to the primary hypothesis that similar improvements in the inflammation and 
ventilation outcomes would be observed between healthy adults and adults with asthma, our 
findings showed an improvement in salivary levels of inflammation among the asthma group 
only, and improvements in ventilation among the healthy control group only. These findings 
offer novel insight into the benefits of HIIT for reducing salivary levels of inflammation among 
adults with asthma and also points to potential limitations of improving ventilation outcomes as a 
result of EIBC.  
Physiological Outcomes  
In contrast to the primary hypothesis that a 6-week HIIT intervention would lead to 
improvements in IL-8 and IL-1Ra among adults with asthma and healthy controls, our findings 
showed no changes in IL-8 in either group and a reduction in IL-1Ra among the asthma group 
only.  
Our findings of a reduction in salivary IL-1Ra levels following exercise training may be related 
to the reduction observed in salivary IL-1β levels among adults with asthma. IL-1β is elevated in 
the sputum of individuals with stable and exacerbating asthma [100] and the dysregulation 
between the IL-1β /IL-Ra ratio is important for the inflammation observed among adults with 
asthma [117]. Therefore, our findings suggest that HIIT may serve to improve the IL-1β /IL-Ra 




ratio and these changes can be observed via salivary levels of each cytokine. Salivary assessment 
of cytokines is a non-invasive and efficient method, which may be preferable over a serum 
sample and thus, have important clinical implications among this population.  
Secondly, in contrast to our hypothesis that adults with asthma and healthy controls would 
experience similar improvements in ventilation, we found that healthy controls were able to 
improve maximal ventilation, maximal respiratory rate, and tidal volume; however, adults with 
asthma were not. Previous research among healthy adults (n=72) reported similar improvements 
following 3-weeks of high intensity exercise [184]. Among adults with asthma, following 10-
weeks of continuous exercise training no changes in VEmax, VTmax, or RRmax was observed 
[185]. Despite no changes in ventilatory outcomes among adults with asthma in response to 
exercise training, cardiorespiratory fitness is improved. Significant improvements among adults 
with asthma and healthy controls and these improvements did not differ between groups. This 
finding suggests that a 6-week HIIT intervention is effective in improving fitness regardless of 
an asthma diagnosis. 
 
Psychological Outcomes 
We predicted that a 6-week HIIT intervention would lead to a reduction in anxiety sensitivity 
and exercise specific anxiety among adults with asthma. In support of our hypothesis,  we 
observed a significant reduction in both measures of anxiety. The strength of the effect size 
observed in the ASI-PC subcomponent (Cohens d = 0.6), suggests that a 6-week HIIT 
intervention may play an important role in reducing the anxiety surrounding physical sensations 
commonly experienced during exercise as well as during an asthma exacerbation (i.e. shortness 




of breath). These findings are in line with previous research that has reported that exercise 
frequency and exercise intensity play an important role in reducing anxiety sensitivity [198, 199] 
We also observed a significant reduction in asthma-related barriers to exercise participation and 
reported significantly reduced anxiety at the thought of exercise using the VAS. These findings 
are in line with previous research implemented a VAS to assess anxiety among adults with 
asthma,  which noted significant improvements in feelings of fear surrounding breathlessness 
during exercise following a 10-week HIIT swimming intervention [197]. The use of VAS in this 
dissertation is a considerable strength as it allows for a greater understanding of subjective 
perceptions of each participants EIBC. VAS have high internal consistency and are sensitive to 
change [238]. Although statistically significant changes were not observed in the “how confident 
you feel in your ability to exercise without experiencing asthma symptoms (without taking 
medication)” VAS, a trend towards significance to medium was observed (p=0.053, Cohens d = 
0.4). This finding, paired with the significant improvements  and medium to large effect sizes in 
the VAS ““how much of a barrier is your asthma to exercise participation” (mean pre = 3.7 ± 
2.7, mean post = 2.0 ± 1.2; p=0.002, Cohens d = 0.8) and “how much anxiety you experience due 
to your asthma when thinking about exercise participation” (mean pre = 2.8 ± 2.5, mean post = 
1.3 ± 1.1; p=0.005, Cohens d = 0.5) suggesting that not only is HIIT able to elicit statistical 
changes but large differences in perceived asthma and exercise related anxiety.  
 
Clinical Outcome 
Our findings of an improvement in asthma control following a 6-week HIIT intervention, is in 
line with our hypothesis. Although previous research has observed similar findings following 




continuous exercise training, [10] our findings are the first to demonstrate improvements in 
asthma control following HIIT. This novel finding, allows for greater diversity in exercise 
prescription among health care professionals working closely with the asthma population. 
Research has shown greater adherence to exercise when personal preference and exercise 
enjoyment are incorporated [160]. HIIT may allow for greater exercise adherence among those 
adults with asthma who may prefer HIIT over continuous exercise training, while still reaping 
the benefits of improved asthma control.  
The improvements in the physiological, psychological, and clinical outcomes that were reported 
throughout this dissertation offer further evidence in support of exercise, and in particular HIIT, 
as a viable adjunct method of disease management among adults with EIBC..  
Secondary Overarching Goal 
The secondary overarching goal of this dissertation was to examine the interconnectedness 
between the physiological and psychological domains of health. There exists a close relationship 
between these domains, which has been noted in regards to anxiety and inflammation, in that 
high anxiety is positively associated with elevated inflammation [239]. To determine whether the 
data within this dissertation offered further support to this link, we tested our sample by running 
Pearson’s Correlation coefficient. Our results revealed that IL-8 was the only cytokine we 
assessed that was moderately correlated anxiety.  A moderate correlation (r=0.4) between 
salivary levels of IL-8 and anxiety among adults with asthma, while a small relationship was 
observed among healthy controls (r=0.2) was observed. Our findings further the evidence that 
those with higher levels of anxiety exhibit higher salivary levels of IL-8. Taking this one step 
further, we also analyzed our data to examine the relationship between asthma control and 
inflammation. Our findings did not show a strong correlation between the two (r=0.3); however, 




previous research has suggested that asthma control is linked with levels of inflammation, in that 
those with worse asthma control have higher levels of inflammation [240]. It is likely that the 
homogeneity of our sample in terms of asthma control limited our ability to see a relationship 
between varying levels of asthma control and inflammation. An important avenue for future 
research will be to further examine the relationship between salivary levels of inflammation and 
asthma control following HIIT, among adults with varying levels of asthma control. The 
additional analyses of our data, further illustrate the importance of taking a broader approach to 
research in order to better understand the link between the physiological and psychological 
components of health and how this contributes to clinical outcomes.   
Limitations 
The results shared within this dissertation should be interpreted in light of the limitations 
addressed in Chapters 3-7, as well as the following. The lack of a control group of adults with 
EIBC limits the generalizability of our findings within the EIBC population. As well, in order to 
better determine the benefits of HIIT among adults with asthma, including a second treatment 
group composed of moderate intensity continuous exercise among adults with EIBC would have 
shone light on the ideal intensity of exercise for improving various components of health among 
this population. Finally, the assessment of cytokines via the saliva is a substantial limitation; 
however, incorporating an additional method of cytokine analysis (i.e. via the blood) would have 
given strength to our findings as well as provided valuable insight into the validity and reliability 
of using saliva samples to assess inflammation pre and post-exercise training among adults with 
and without EIBC. Despite these limitations, the results shared within this dissertation offer 
novel insight into the physical, psychological, and clinical impact of HIIT among adults with 
EIBC. 





This dissertation provides foundational insight into the physiological, psychological, and clinical 
benefits of HIIT among adults with asthma and healthy controls. Future research should conduct 
large scale randomized controlled trials to determine the optimal and preferred mode of exercise 
training (e.g. HIIT vs continuous exercise) among adults with asthma. Determining an optimal 
and most preferred mode would aid in exercise prescription and could have an important impact 
on exercise adherence among this population. As well, future research should expand on the sex 
differences analyses within this dissertation in a larger sample to better understand the role of sex 
and the benefits of HIIT among adults with asthma. Finally, future research examining the 
impact of HIIT among adults with asthma should implement mid-intervention assessments in 
order to better understand the rate of improvements within all domains of health. A better 
understanding of the rate of change associated with HIIT would inform timelines for exercise 
interventions and training programs.  
Conclusions  
In conclusion, this dissertation sought to determine the impact of a 6-week HIIT intervention on 
physical fitness, inflammation, ventilation, and anxiety among adults with and without asthma. 
Furthermore, we sought to determine the effectiveness of a HIIT intervention on improving 
asthma control.  This body of work demonstrates that a 6-week HIIT intervention leads to 
statistical and clinically meaningful improvements in salivary levels of inflammation, 
cardiorespiratory fitness, anxiety, and asthma control among adults with EIBC.  These findings 
offer novel insight into the importance of assessing the impact of exercise interventions on the 
various components of health in order to improve the health of adults with and without asthma.   
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 Appendix A: Questionnaires  
A1) Eligibility and Demographic Questionnaire 
A2) Physical Activity Readiness Questionnaire Plus 
A3) Asthma Control Questionnaire – 7 
A4) Mini Asthma Quality of Life Questionnaire 
A5) Body Sensations Questionnaire 
A6) Generalized Anxiety Disorder – 7 
  




A1. Eligibility and Demographic Questionnaire 
 
1. Age:    
 
2.  Sex:    
 
 Female    Male    
 If you are a female, how many days has it been since the start of your last period?  
  
 




4. Do you currently have a rescue/reliever inhaler? (example: Ventolin or Bricanyl, blue puffer) 
a. Yes 
b. No 
If yes, please write the name of the medication here:      
            
  
 
5. Are you currently taking any prescription or over the counter medications regularly (not 
previously listed in question 5)?  
a. Yes 
b. No 
If yes, please list the medications here:        
            
             
6. When you are exercising at a moderate to vigorous intensity (i.e. your heart is beating faster and 
you begin to sweat) do you experience any of the following symptoms? Choose all that apply: 
a. Coughing 
b. Wheezing 
c. Chest Tightness 
d. Increased Mucus Production 
e. Difficulty Breathing 
 




      If yes, please describe the injury here:        
            
             
8. If you are a female, are you currently pregnant?  
a. Yes 






9. Have you ever been a regular smoker? 
a. Yes 
b. No 
If yes, please indicate for how long:        
           
    
 




11. In a typical week, how much time to you spend participating in moderate to vigorous physical 
activity? 
a. Yes  
b. No 
Please describe the type of physical activity you engage in (i.e. walking, jogging, 
cycling):           
            
             
 
12. Please list an emergency contact 
 Name:        
 Relationship:        
 Phone Number:      
  



























A3. Asthma Control Questionnaire 
 














A4. Mini Asthma Quality of Life Questionnaire
e 














A5. Body Sensations Questionnaire 
BSQ 
 
Below is a list of body sensations that may occur when you are nervous or frightened. Please circle how 
afraid you are by circling any of the numbers from 1 to 5 on the scales below. 
Please rate all items in that matter. 












1.  Heart palpations....................................................... 1 2 3 4 5 
2.  Pressure, pain, or heavy feeling in chest................. 1 2 3 4 5 
3.  Numbness in legs or arms.......................................  1 2 3 4 5 
4.  Tingling in fingertips............................................... 1 2 3 4 5 
5.  Numbness in another part of body..........................  1 2 3 4 5 
6.  Feeling short of breath............................................  1 2 3 4 5 
7.  Dizziness.................................................................  1 2 3 4 5 
8.  Blurred or distorted vision......................................  1 2 3 4 5 
9.  Nausea.....................................................................  1 2 3 4 5 
10. It scares me when I become short of breath........... 1 2 3 4 5 
11. Having "butterflies" in my stomach........................ 1 2 3 4 5 
12. Feeling a "knot" in my stomach.............................  1 2 3 4 5 
13. Having a lump in my throat................................... 1 2 3 4 5 
14. Sweating................................................................. 1 2 3 4 5 
15. A dry throat............................................................ 1 2 3 4 5 
16. Feeling disoriented and confused............................ 1 2 3 4 5 
 
 

















Appendix B: Scales 
 
B1) Ratings of Perceived Exertion 
B2) Ratings of Perceived Dyspnea 
B3) One-Item Feelings Scale 
B4) Physical Activity Enjoyment Scale  
B5) Anxiety Sensitivity Index – 3 
B6) Visual Analog Scales 
  




B1. Borg Scale of Perceived Exertion 
 
6 – No Exertion at all 
7 – Extremely Light 
8 
9 – Very Light 
10 
11 – Light 
12 
13 – Somewhat Hard 
14 
15 – Hard (heavy) 
16 
17 – Very Hard 
18 
19 – Extremely Hard 
20 – Maximal Exertion 
 
  




B2. Revised Borg Scale for Grading Severity of Dyspnea 
 
       0 – Nothing at all 
       1 – Just Noticeable 
       2 – Very Slight 
       3 – Slight 
       4 – Slight/Moderate  
       5 – Moderate 
       6 – Some Difficulty 
       7 – Moderately Severe 
8 - Severe 
       9 – Very Severe 
      10 – Panic Level, Maximal Shortness of Breath 
  




B3. One-Item Feelings Questionnaire Feeling Scale (FS) 
(Hardy & Rejeski, 1989) 
+ 5 – Very Good 
4 
3 – Good 
2 
1 
0 – Neutral 
-1 – Fairly Bad 
-2 
-3 - Bad 
-4 
-5 – Very Bad 
  





B4. Physical Activity Enjoyment Scale 
Please rate how you feel at the moment about the physical activity you have been doing. •  
1 2 3 4 5 6 7 
 
I enjoy it        I hate it 
1 2 3 4 5 6 7 
I feel bored         I feel interested 
1 2 3 4 5 6 7 
I dislike it         I like it  
1 2 3 4 5 6 7  
I find it pleasurable        I find it unpleasurable  
1 2 3 4 5 6 7 
I am very absorbed in this activity   I am not at all this activity absorbed in this activity 
1 2 3 4 5 6 7 
It's no fun at all        It's a lot of fun  
1 2 3 4 5 6 7 
I find it energizing        I find it tiring 
1 2 3 4 5 6 7 
It makes me depressed       It makes me happy 
1 2 3 4 5 6 7 
It's very pleasant        It's very unpleasant 
1 2 3 4 5 6 7 
 




I feel good physically while doing it     I feel bad physically while doing it  
1 2 3 4 5 6 7 
It's very invigorating        It's not at all invigorating 
1 2 3 4 5 6 7 
I am very frustrated by it       I am not at all frustrated by it 
1 2 3 4 5 6 7 
It's very gratifying        It's not at all gratifying  
1 2 3 4 5 6 7 
It's very exhilarating        It's not at all exhilarating 
1 2 3 4 5 6 7 
It's not at all stimulation      It's very stimulating  
1 2 3 4 5 6 7 
It gives me a strong sense      It does not give me any sense  
 of accomplishment                  accomplishment at all 
1 2 3 4 5 6 7  
It's very refreshing        It's not at all refreshing 
1 2 3 4 5 6 7 
I felt as though I would rather be     I felt as though there was  
doing something else      nothing would rather be doing 
  1 2 3 4 5 6 7 
 
Item is reversed scored(i.e..1=7,2=6,. .. 6=2,7=1). 
 
 




B5. Anxiety Sensitivity Index - 3 
ASI-3 
 
Please circle the number that best corresponds to how much you agree with each item. If any items 
concern something that you have never experiences (e.g. fainting in public) answer on the basis of how 
you think you might feel if you had such an experience. Otherwise, answer all items on the basis of your 






Some Much Very 
much 
1. It is important for me not to appear nervous.  0 1 2 3 4 
 
2. When I cannot keep my mind on a task, I worry that 
I might be going crazy. 
0 1 2 3 4 
 
3. It scares me when my heart beats rapidly.  0 1 2 3 4 
 
4. When my stomach is upset, I worry that I might be 
seriously ill. 
0 1 2 3 4 
5. It scares me when I am unable to keep my mind on a 
task. 
0 1 2 3 4 
6. When I tremble in the presence of others,  
 I fear what people might think of me.  
0 1 2 3 4 
 
7. When my chest feels tight, I get scared that I won’t 
be able to breathe properly.  
0 1 2 3 4 
 
8. When I feel pain in my chest, I worry that I’m going 
to have a heart attack.  
0 1 2 3 4 
 
9. I worry that other people will notice my anxiety.  0 1 2 3 4 
 
10. When I feel “spacey” or spaced out I worry that I 
may be mentally ill.  
0 1 2 3 4 
11. It scares me when I blush in front of people.  0 1 2 3 4 




Note. Scoring: Physical concerns = sum of Items 3, 4, 7, 8, 12, 15. Cognitive concerns = sum of Items 2, 




12. When I notice my heart skipping a beat, I worry that 
there is something seriously wrong with me.  
0 1 2 3 4 
 
13. When I begin to sweat in a social situation,  
 I fear people will think negatively of me.  
0 1 2 3 4 
 
14. When my thoughts seem to speed up, I worry that I 
might be going crazy.  
0 1 2 3 4 
 
15. When my throat feels tight, I worry that I could 
choke to death.  
0 1 2 3 4 
16. When I have trouble thinking clearly, I worry that 
there is something wrong with me.  
0 1 2 3 4 
 
17. I think it would be horrible for me to faint in public.  0 1 2 3 4 
18. When my mind goes blank, I worry there is 
something terribly wrong with me.  
0 1 2 3 4 
 




B5. Visual Analog Scale Questions (100mm) 
 
1) Please indicate how much your asthma impacts your willingness to exercise by placing an x along 
the line below: 
 
             




2) Note how much anxiety you experience due to your asthma when thinking about exercise 
participation: 
 
             





3) Note how confident you feel in your ability to exercise without experiencing asthma symptoms 
(without taking medication): 
             
Not Confident         Extremely Confident 
  




Appendix C: Standard Operating Procedures 
C1) Eucapnic Voluntary Hyperpnea Challenge 
C2) Saliva 
C3) Near Infrared Spectroscopy  
  







C1. Eucapnic Voluntary Hyperpnea Challenge  
 
Materials: 
o Medical Scale 
o Handheld Spirometer 
o Metabolic Cart 
o Mouth Piece 
o Dry Air 
o Nose Clip  
Participant Instructions: 
o With-hold long acting medication 48 hours prior to testing 
o With-hold short acting medication 8 hours prior to testing 
o Refrain from consuming caffeinated beverages at least 2 hours prior to testing 
o Refrain from consuming a heavy meal at least 2 hours prior to testing 
o Bring shorts and sneakers to testing session 
o Bring  current rescue medication to testing session  
 
  
 Preparation and Instructions  





Sample Collection Instructions:                
 
Step 1
• Calibrate metabolic cart
Step 2
• Ensure participant has medication
Step 3
• Assess height and weight
Step 4
• Demo Spirometery 
Step 5
• Have participant complete spirometery according to ATS guidelines
Step 6
• Determine ventilation range
Step 7
• Fit participant with mouthpiece
Step 8
• Provide participant with 30 second practice breathing dry air at target ventilation 
rate
Step 9
• Start stop watch to begin challenge
Step 10
• End challenge at 6 minutes
Step 11
• Re-assess lung function post challenge at 0, 5, 10, 15, and 20 minutes post
 EVH Challenge Procedures  





Storage: Data will be immediately coded and stored on the password protected laptop of the student 
researcher and backed up onto a password protected USB. 
Data Analysis: Lung function will be assessed pre and post challenge at minutes 0, 5, 10, 15, and 20. The 
decline in lung function will be determined using the following equation:  
 
% fall in FEV1 = 100 × [FEV1 (pre-challenge) – (lowest value for FEV1 post-challenge)] FEV1 pre-
challenge 
 
Confirmation of EIBC will be determined by a decline in FEV1 ≥12%. 
  
 Sample Handling Procedures  




C2. Saliva  
Materials: 
o Cryovials 
o Saliva Collection Aid 
o Bar-Coded Labels 
o Cryostorage Box 
o Medical Gloves 
o Water 
Instructions:   
o To ensure participants have followed instructions, document: 
o consumption of alcohol, caffeine, nicotine, and prescription/over-the-counter medications 
within the previous 12 hours, 
o consumption of meal within the previous 60 minutes,  AND 
o consumption of foods with high sugar, acidity, or caffeine content, immediately before 
sample collection. 
o Document the participant’s physical activity levels and the presence of oral diseases or injury. 
o Have participant rinse mouth with water (provided by researchers) to remove food residue and 
wait at least 10 minutes after rinsing to collect sample. 
  
 Preparation and Instructions  





Sample Collection Instructions:                
 
Step 1
• Provide participant with water to rinse their mouth and wait 10 minutes before 
sample collection
Step 2
• Put on medical gloves
Step 3
• Remove cap from cryovial
Step 4
• Remove saliva collection aid from packaging and place securely into cryovial
Step 5
• Instruct participant to allow saliva to pool in mouth
Step 6
• With head tilted forward, participants should drool through the saliva collection 
aid to collect saliva in the cryovial
Step 7
• Repeat until sufficient sample (2mL) is collected
Step 8 
• *Special Consideration*
• If sample contains visible blood re-collect sample
Step 9
• Reserve air space in the vial to accommodate the expansion of saliva during 
freezing
Step 10
• Replace cap onto cryovial
Step 11  
• Code sample, record date and time and place immediately into -80 freezer
 Saliva Collection Procedures  








Storage: Samples will be collected using Salimetrics high quality polypropylene 2ml cryovials 
(Salimetrics Item No. 5002.01). Samples will be transported in accordance with the Transportation of 
Dangerous Goods Act and regulations. Briefly, all samples will be securely sealed and packaged prior to 
transport. To allow for multi-analyte testing, samples will be aliquoted to smaller vials within a biosafety 
cabinet using aseptic technique and guidelines as outlined in the UOIT Biosafety manual. Samples will be 
sealed tightly and immediately coded using labels recommended for freezing (i.e. cryolabels) and placed 
into a -80 degree freezer in Dr. Dogra’s laboratory and stored until analysis. 
Analysis: All samples will be handled in a level 2 Bio-Safety Cabinet in Dr. Jones Taggart laboratory. 
The student researcher has completed the Laboratory Bio-Safety training program and has been included 
on Dr. Jones Taggart’s biosafety certificate.  During analysis, one saliva sample from each participant 
collected at baseline will be combined to run a pooled sample cytokine array. As well, one saliva sample 
from each participant collected following the first HIIT session will be combined to run a pooled sample 
cytokine array. Results from the pooled analysis will determine the specific cytokine arrays that will be 
used for subsequent salivary analyses. Multi-analyte testing will occur and each analyte sample will be 
analyzed at the same time to avoid multiple freeze thaw cycles.  
Sample Disposal: Saliva samples will be disposed using the UOIT pre-approved protocol as outlined in 
the Biosafety Manual, which involves autoclaving for at least 30 minutes at 121 C prior to disposal in a 
regular garbage 
 Sample Handling Procedures  




C3. Near Infrared Spectroscopy SOP 
 
Materials: 
o Near Infrared Spectroscopy (NIRS) Probe 
o Black Cloth 
o Double Sided Tape 
o Tensor Bandage 
Participant Instructions: 
o Shave upper thigh 
o Wear shorts such that upper thigh can be accessed as shown below: 
 
  
 Preparation and Instructions  





Sample Collection Instructions:                
 
Step 1
• Calibrate NIRS equipment
Step 2
• Have participant change into shorts
Step 3
• Ensure thigh is shaved
• If not, shave area 
Step 4
• Place double sided tape on NIRS probe and place on upper right and left thigh
Step 5
• Cover probe with black cloth
Step 6
• Place tensor bandage over probe and black cloth
Step 7
• Click "ok" on NIRS computer to begin data collection
Step 8
• Click "stop" on NIRS compute to end data collection post exercise
Step 9
• Remove tensor bandage, black cloth, and NIRS probe
Step 10
• Code participant data on NIRS computer and store on password protected 
computer and USB
 NIRS Collection Procedures  





Storage: Data will be immediately coded and stored on the password protected laptop of the student 
researcher and backed up onto a password protected USB. 
Analysis: All data will be cleaned in Microsoft Excel. Any down sampling will occur in the NIRS 
software (Artinis Oxymon III, Netherlands). 
 
  
 Sample Handling Procedures  




Appendix D: Figures 
 
1) Handheld Spirometry 
2) Eucapnic Voluntary Hyperpnea Challenge 
3) Near Infrared Spectroscopy Probe 
4) Near Infrared Spectroscopy System 
5) PhysioFlow Enduro 
6) Direct Maximal Exercise Test on Cycle Ergometer 
  




H1. Handheld Spirometry 
 
 





























































































O’Neill C, Dissertation 
 
203 
 
 
